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SMALL SCALE SERVICE RELATED PROJECT
A Profile of One Years Clinical Psychology Service to the Community Mental
Health Team. Lanarkshire.
Lisa Cameron, Department of Psychological Medicine, 
University of Glasgow.
Written in accordance for submission to Clinical Psychology Forum, 
(Author’s notes in Appendix 1)
Abstract
The present study is concerned with team members attitudes and satisfaction towards 
the Clinical Psychology service within the Hamilton Community Mental Health Team 
(CMHT). It also aims to determine whether the psychology service is meeting the 
objectives which it initially set. These include treating the seriously mentally ill and 
working in a multi-disciplinary way. Information was gathered from client case files 
and team members completed a questionnaire in order to assess their views.
Results from the study indicated that team members and community agencies are 
utilizing the Clinical Psychology service to the CMHT. Team members indicated that 
they value the individual work which psychology undertakes with clients and that they 
would like psychology to become involved in team training. Results also demonstrated 
that the majority of team members are satisfied with the present service and that it is 
fulfilling it’s initial objectives.
Key words: Community Mental Health 
Teams, Clinical Psychology.
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Introduction
The implementation o f ‘Community Care’ since the Griffiths report (1982) enabled 
many people who had received long-term psychiatric care to relocate to the community. 
In order to meet their complex healthcare needs, joint working was encouraged between 
health and social services which has led to the widespread development of Community 
Mental Health Teams (CMHT’s).
As CMHT’s have become a major focus of service provision, research has been 
undertaken into their work. Onyett & Ford (1996) described CMHT’s as “a cost 
effective option which is valued by users, carers and referrers”. Additionally, Mearson 
et al (1992) site that the work undertaken by CMHT’s is clinically effective.
The Role of Clinical Psychologists
In recent years clinical psychologists have undertaken active roles within CMHT’s. 
Their involvement has been encouraged by research which demonstrates the usefulness 
of psychological therapies for clients with serious mental illness (Falloon, 1985; Tarrier, 
1989). In order to define the role of psychologists within CMHT’s, research has been 
undertaken into team member’s perceptions of their work. In a survey of 5 CMHT’s 
Cushion (1997) found the main roles of a clinical psychologist to be assessment and 
individual work with clients. A similar study by Osbome-Davies (1996) described the 
main services provided by psychology to the CMHT as clinical work and training.
Those questioned however, were found to have little understanding of the contribution 
of clinical psychologists, perceiving them as “a virtually unknown professional group”.
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The Present Study
The present study in relation to those discussed above aims to assess team member’s 
attitudes and satisfaction toward a recently developed Clinical Psychology service 
within a CMHT. It also aims to determine whether the psychology service is meeting 
the objectives which it initially set.
The Hamilton CMHT became operational in January 1992. It was developed as a joint 
initiative between Lanarkshire Healthcare NHS Trust and Strathclyde Regional Council. 
Its aims are to provide a multi-disciplinary service to individuals/families with severe 
enduring mental health problems and complex needs. The first Clinical Psychologist 
was appointed to the team on a part time basis in February 1996. The psychologist has 
4 sessions per week with the team and the style of the service is that she is based within 
team offices. At the time of the study, the psychology service to the CMHT had been 
running for over one year.
The main aims of the present study are outlined as follows:-
• Firstly, to assess team members views regarding the clinical psychology service and 
their understanding of the work of the Psychologist. This included views about the 
possible direct and indirect roles of psychology within the CMHT, and team members 
understanding of the referral system.
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• The second aim of the study was to assess the performance of the service in relation 
to its initial objectives. The objectives of the psychology service to the CMHT were 
operationally defined within the study as ‘multi-disciplinary work’ and focusing upon 
the ‘treatment of the seriously mentally ilT. These objectives were outlined by the 
psychologist on her arrival to the team and meet with the overall service principles of 
the Hamilton CMHT.
• The third aim of the study was to assess team member’s satisfaction with the service 
and their views regarding future service developments.
Method
1. Procedure:
The procedure of the present study involved gathering two kinds of information. Firstly, 
permission was given to obtain information from client case files. Using this data, an 
in-depth review of the referrals made to psychology was undertaken. Secondly, 
following a review of the current literature, a questionnaire was devised which 
addressed current research themes (e.g. team member’s perceptions of psychology 
within the CMHT). The questionnaire was also tailored in order to answer research 
questions specifically relating to the psychology service in the Hamilton CMHT. 
Administration of the questionnaire involved meeting with team members, and 
requesting that they complete the questionnaire.
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2. Participants:
The study was defined to team members as an evaluation of the psychology service to
the CMHT. There are twelve CMHT members whose designations are as follows:
7 Community Psychiatric Nurses 
1 Psychiatrist 
1 Registrar
1 Occupational Therapist 
1 Social Worker 
1 Counsellor
In all, eleven team members took part in the study (one was on holiday).
3. Materials:
Information from Client Case Files:
(a). Demographic information was obtained from client case files in order to provide 
background data to the study.
(b). Information from client case files was also utilized to quantitatively determine 
whether the psychology service was treating the ‘seriously mentally ill’. Therefore, the 
percentage of referrals which met the criteria for serious mental illness as defined by 
CMHT specifications* was calculated.
* ( ‘Serious mental illness’ was classified by the Care Programme Approach specification which is used in 
Lanarkshire. This specifies that clients should have a previous psychiatric diagnosis and an enduring mental 
illness which is severely disabling to their lives).
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( c ). Additionally, the referrals made within the first year of the service were 
categorized in order to quantify the types of cases which were being referred to 
psychology. This was undertaken by categorizing case file information in accordance 
with the referral categories used in the questionnaire. This enabled comparison between 
the referrals made to psychology and team member’s perceptions of the referrals made. 
All of the categorizations made to referrals were verified by the team psychologist.
(d). Information from client case files was also used to determine the percentage of the 
psychologist’s cases which involved multi-disciplinary work. The number of 
psychology clients being treated by additional team members was therefore calculated.
(ii) The Questionnaire: The questionnaire (see Appendix 1) was structured to answer 
research questions as follows-
(a). Views o f Psychology - In order to assess team member’s views about the psychology 
service to the CMHT, participants were required to answer questions about the possible 
direct and indirect roles of clinical psychology. Participants were also asked about the 
referral system in order to determine the reasons they refer to psychology and whether 
they use psychology’s referral form.
(b)Service Objectives - In order to provide a qualitative measure of whether the 
psychology service was meeting its objectives, participants answered questions about the
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types of cases they usually refer to psychology and the degree of communication which 
they have with the psychologist. This gave a descriptive account of whether clients with 
serious mental illness were being referred and the level of multi-disciplinary working 
which was taking place.
( c) Service Satisfaction - Team members were asked to define their level of satisfaction 
with a number of aspects of the psychology service. This included referral ability, 
waiting time, psychologists involvement in the team, consultation and the work of the 
psychologist.
(d) Future Developments - In order to define team member’s views regarding future 
developments, they were required to rate their first and second preferences from a list of 
possible future developments outlined previously by the team psychologist. Some space 
was also allocated in order that they could offer their own ideas.
Results
Demographic Information: Within the first year of the service, psychology received 40 
referrals. Twenty-one referrals were males (52.5%) and nineteen were females (47.5%). 
Of the referrals made, 31 (77.5%) came from team members and 9 (22.5%) came from 
outside agencies. Table 1 indicates the numbers of referrals made to psychology from 
each profession. Of those referred, 13 clients completed treatment, 13 dropped out of 
treatment, 9 failed to attend their initial appointment and 5 were referred on to different 
services.
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A: Views of Psychology:
1. The Psychologists’ Roles:
(i). Direct Roles - Team members were asked to choose from questionnaire data up to 5 
of what they considered to be the most important direct roles of psychology in the 
CMHT. They were then required to rank order their choices from 1-5,41’ being the most 
important role. Eighty-one percent of team members chose ‘Individual Work with 
Clients’ to be the most important direct role of the psychologist (mean rank 1.7). 
‘Psychological Assessment’ was rated by 55% of team members as the second most 
important direct role. Table 2 outlines the direct roles chosen by most team members.
(u) Indirect Roles - Team members were asked to choose from questionnaire data up to 
5 of what they considered to be the most useful indirect roles of psychology within the 
CMHT. They were then required to rank order their choices from 1-5, 1 being the most 
useful indirect role. Fifty-five percent of team members rated ‘Team Training in 
Psychological Issues’ to be the most useful indirect role which psychology could 
undertake (mean rank 1.7). Education/Health Promotion was chosen by 36% of team 
members as the second most useful role (mean rank 2.2). Table 3 outlines the indirect 
roles chosen by most team members.
2. The Referral System: In order to determine whether team members use the 
psychology referral form, they were required to define from a list of 5 types of referral
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procedure that which they used most often. Forty-five percent of team members 
indicated that they use a ‘combination of referral procedures’. The distribution of 
responses was large which would suggest that they do not use a set referral procedure 
(Figure 1). Team members were also asked to rate on the questionnaire their 3 most 
common reasons for referring cases to psychology. They then ranked these reasons from 
1-3,11 ’ being the most usual reason for referral. Seventy-three percent of team 
members chose the most usual reason for referral as viewing the ‘problem as 
psychological’ (mean rank 1.2). Fifty-five percent of team members chose ‘Gaining an 
alternative opinion’ as the second most usual reason for referral (mean rank 2.7). No one 
indicated referring to psychology on the basis of the earliest available appointment.
Table 4 outlines the referral procedures chosen by most team members.
B: Service Objectives:
Treating Clients with Serious Mental Illness:
(0. Quantitative Data: Information from case notes indicated that 73% of the cases 
which were referred to psychology within the first year met the criteria for serious 
mental illness. Additionally, information from client case files indicated that the main 
types of problem referred to psychology were ‘multiple difficulties’ (e.g. people with 
more than one problem) and ‘complex enduring anxiety’. Table 5 outlines the number 
of referrals made for each problem type.
(ii.) Qualitative Data: In comparison with the quantitative data, team members 
perceptions of the types of cases referred to psychology was assessed. Team members
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were requested to indicate on the questionnaire up to five of the most frequent types of 
cases which they refer to psychology. They ranked these from 1-5 in terms of frequency,
4 r  being the most frequent referral type. The large distribution of responses in terms of 
ranking indicated that team members differ in the types of cases which they most 
usually refer to psychology. However, when responses to each referral type were 
grouped, a good level of consistency was found (Table 6). Ninety-one percent of team 
members ranked anxiety cases within their five most frequent referral types to 
psychology (mean rank 2.7). This was followed by Obsessive Compulsive disorder 
which was rated by 82% of team members within their five most frequent referral types 
(mean rank 2.1). Seventy-three percent of team members chose Trauma (mean rank 1.9) 
and also Depression (mean rank 3.1) within their five most frequent referral types to 
psychology.
Multi-disciplinary Work:
(i). Quantitative Data - Multi-disciplinary working was looked at in terms of the number 
of the psychologists cases which an additional team member was involved with. 
Information from client case files in relation to this requirement indicated that 40% of 
the psychologists’ cases involved multi-disciplinary work.
fii )Oualitative Data - Multi-disciplinary working was also analysed in terms of team 
members perceptions of the amount of communication which they have with 
psychology regarding joint casework. Team members were asked to describe the level 
of communication which they have with psychology on a scale, ranging from ‘never
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communicate’ to ‘always communicate’. There was a relatively wide distribution of 
responses (Figure 2) which would suggest that there is more communication between 
psychology and some team members than others.
C: Service Satisfaction:
Team members were asked to define their level of satisfaction with a number of aspects 
of the psychology service on a scale ranging from ‘very satisfied’ to ‘very dissatisfied’ 
(Table 7). Most team members rated their opinion of the psychology service in terms of 
‘satisfied’ or ‘very satisfied’ which would indicate that they feel positive about the 
service. Waiting time to see a psychologist was one aspect of the service which a small 
number of team members described in terms of dissatisfaction. (Additionally, two team 
members who had not yet used the psychology service did not answer the service 
satisfaction questions).
D: Future Developments:
In order to measure team members attitudes to possible future developments they were 
required to rank on the questionnaire their first and second preferences from a list of 
possible future developments which were defined by the team psychologist. ‘Staff 
training in Psychological Issues’ was chosen by 73% of team members as the most 
important future service development (mean rank 1.1). No one offered any of their own 
ideas regarding future service developments. Table 8 outlines the types of future 
development chosen by most team members.
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Discussion
Information from the study indicates that most disciplines within the CMHT have made 
referrals to the psychology service within its first year of operation. This suggests that 
team members are aware of the service and are utilizing it for clients. In addition, a 
quarter of psychology’s referrals came directly from outside agencies (e.g. GP’s, 
Community Projects). This may indicate that the service is also being recognized 
within the community.
With regards to the most important direct role of psychology within the CMHT, eighty- 
one percent of team members chose ‘individual work with clients’. ‘Psychological 
Assessment’ was rated by most team members as psychology’s second most important 
direct role. That individual clinical work is viewed as psychology’s most important role 
within the CMHT concurs with previous research from Cushion (1997). It would seem 
therefore, that team members value the skills which psychologists have working on an 
individual basis with CMHT clients.
The majority of CMHT members indicated that the most useful indirect roles of 
psychology are ‘Team Training in Psychological Issues’ and ‘Health 
Education/Promotion’. Team Training in Psychological Issues’ was also chosen as the 
most useful future service development. It seems clear from these findings that the 
CMHT members would like psychology to include team training within their remit. 
Indeed, it may be one of the advantages of working within a multi-disciplinary setting 
that professionals can organize inservice training to learn from each others skills.
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With regards to the referral system, results from the study suggest that referrals are 
made in a variety of ways and that psychology’s referral form is not always being 
utilized. Team members did make reference to the referral form as part of the 
‘combination of referral methods’ which they use but they also indicated that they 
additionally like to discuss the referrals with psychology.
The majority of team members said that they usually refer what they consider to be 
‘psychological type’ cases to psychology. This suggests that effort is being made to 
make referrals which are appropriate to the service. This finding contradicts other 
authors suggestions that the key criteria for allocation of referrals within CMHT’s is 
“whoever has a free space in their diary” (Searle, 1991). No one in the present study 
acknowledged using this criteria for referral.
An additional aim of the study was to assess whether psychology was meeting its initial 
objectives. With regards to ‘multi-disciplinary working’, qualitatively there was a large 
distribution of responses in relation to the level of communication which team members 
have with psychology in relation to joint casework. This indicates that multi­
disciplinary collaboration may be taking place between psychology and some team 
members but not others. Increased communication between psychology and team 
members with whom they do not often collaborate may be helpful to maximize multi­
disciplinary working. As a quantitative measure of multi-discipiinary working, the 
number of the psychologists cases which an additional team member was involved with
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was calculated. Forty percent of psychology’s clients were also involved in work with 
an additional team member. This figure may seem low however it compares favorably 
in relation to previous research findings which indicate that “it is rare if more than 13% 
of CMHT cases have more than one worker involved” (Searle, 1991).
Case note information indicated that 73% of the referrals made to psychology met the 
criteria for serious mental illness. Additionally, classification of the referrals made 
suggested that most cases referred to psychology were for clients classified as having 
‘multiple problems’. This perhaps indicates that the referrals were appropriate to 
psychology in that they required complex case formulation. Qualitatively however, 
many team members ranked anxiety cases as being their most frequent referrals to 
psychology whilst referrals for direct treatment of psychoses were identified by few. 
This may indicate that team members do not as yet view psychology’s main role as 
working with the new techniques which have been developed for psychoses.
With regards to satisfaction with the psychology service to the CMHT, results indicate 
that team members feel positive about most aspects of the service. This includes ability 
to refer to psychology, ability to access a psychological perspective on cases, the 
psychologists work, the waiting list and the level of the psychologist’s involvement 
within the team. A small number of team members described the waiting list in terms 
of dissatisfaction. This perhaps indicates a difficulty with regards team members 
awareness of this part of the service as presently there is no waiting list for psychology.
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In conclusion, team member’s responses clearly suggest a role for clinical psychology 
within the CMHT. Team members indicated that they particularly value the individual 
work which psychology undertakes with clients and that they would also like 
psychology to become involved with team training. Results also demonstrated that the 
majority of team members are satisfied with the present service.
Service Recommendations:
1. To widen communication to include more team members.
2. To educate team members about the type of work which psychologists can undertake 
with clients who have psychosis.
3. To include team training within psychology’s remit.____________________________
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Table 1: Referrals to Psychology in the 1"* year of the Service
Professions Number of Referrals Made
Psychiatry 12 (30%)
Team Members Nursing 11 (27.5%)
Social Work 7 (17.5%)
Occupational Therapy 1 (2.5%)
Other Aeencies G.P.’s 8 (20%)
Community Projects 1 (2.5%)
Table 2: Frequency of Responses to Psychology’s Most Important Direct Role
Rank Type of Direct Role Chosen by 
Most Team Members at this 
Rank
Frequency of Response Mean Rank
1st Individual Work 9 (81%) 1.7
2nd Psychological
Assessments
6 (55%) 2.8
3rd Discussion of Referrals 4 (36%) 3.3
4th Recommendation of therapy 5 (45%) 3.2
5th Cognitive Testing 4 (36%) 4.2
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Table 3: Frequency of Responses to Psychology’s Most Useful Indirect Roles
Rank Type of Indirect Role Chosen 
by Most Team Members at 
this Rank
Frequency of Response Mean Rank
1st Team Training 7(55%) 1.7
2nd Education/Health
Promotion 6 (36%)
2.2
3rd Consultation 1 (9%) 2.9
4th Research 3 (27%) 3.3
5th Supervision 2 (18%) 3.4
Table 4: Reasons for Referral of Cases to Psychology
Rank Reason for Referral Chosen by 
Most Team Members at this 
Rank
Frequency of 
Responses
Mean Rank
1st Psychological Type Problem 8 (73%) 1.2
2nd Alternative Opinion 6 (55%) 2.7
3d Professional Back-up 4 (36%) 2.7
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Table 5: A Profile of the Types of Problems Referred to Psychology Based Upon
Information from Client Case Notes
Type of Problem Number of Referrals
Multiple problems 15
Complex Enduring Anxiety 9
Severe Depression (inc. suicide/self harm) 5
Trauma (incl. Sexual Abuse) 5
Obsessive Compulsive Disorder 3
Schizophrenia 1
Paranoia 1
Sexual Dysfunction 1
Cognitive Assessment 0
Mania/Manic Depression 0
Personality Disorder 0
Table 6: A Profile of the Types of Problems Referred to Psychology Based Upon
Team Members Views
Type of Problem Number of Team Members who 
Rated it within 5 Most Frequent 
Referrals
Complex Enduring Anxiety 10
Obsessive Compulsive Disorder 9
Trauma 8
Severe Depression (inc. suicide/self-harm) 8
Personality Disorder 5
Multiple Problems 4
Schizophrenia 3
Mania/Manic Depression 3
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Table 7; Team Members Level of Satisfaction with the Psychology Service
Level of Satisfaction
Service Questions Very Satisfied Satisfied Dissatisfied Very
Dissatisfied
Ability to refer to psychology 73% 27% 0% 0%
Ability to gain psychological 
Perspective on cases
27% 55% 0% 0%
Psychologists work 9% 73% 0% 0%
Waiting Time 0% 64% 9% 9%
Psychologist involvement with 
Team
9% 64% 9% 0%
Table 8: Future Service Developments
Freauencv of Response
Potential Development 1st Choice 2nd Choice
Team Training 8 1
Group-work with Team 
Members
1 6
Specialist Group-work 0 1
Work with Families/Carers 0 1
Discussion of Complex Cases 2 2
21
Fr
eq
ue
nc
y 
of 
re
sp
on
se
s
Figure 1: How Team Members make Referrals to Psychology
!■ X... , - - - - - - - - - J- - - - - - - -------------------T -----------------------------------1
verbal letter meeting combination
Method of Referral
22
fre
qu
en
cy
 
of 
re
sp
on
se
s
Figure 2: Level of Communication between Psychology and Team
Members6
5
4
3
2
1
0
AlwaysNever Not Often Often Very Often
Frequency of Communication
23
MAJOR RESEARCH PROJECT LITERATURE REVIEW
The Impact of Hepatitis C on Injecting Drug Users and the utility of applying 
HTV research to develop Harm Reduction initiatives.
Lisa Cameron, Department of Psychological Medicine, 
University of Glasgow.
Written in accordance for submission to Addiction (author’s notes in Appendix 2)
Introduction
The aim of this review is to describe Hepatitis C (HCV) and the impact which 
current research suggests it is having upon the Injecting Drug User (IDU) population. 
Prevalence figures among IDU’s are initially outlined and possible risk factors for 
transmission of the virus highlighted. The second part of the review discusses the 
possibility of utilising existing HTV research including education and social 
cognition models of behaviour change (e.g. self-efficacy) in order to develop HCV 
harm reduction strategies.
Part One:
1. The Hepatitis C Virus:
Hepatitis C, previously known as Non A-Non B Hepatitis, was identified in 1989. It 
is a virus which makes its’ home within the liver where it infects and damages cells. 
Physical symptoms of acute HCV include tiredness, nausea and general malaise. As 
these are common symptoms, HCV can remain unidentified for some time. If 
chronic HCV develops however, the health consequences can be potentially fatal. 
These include scarring of the liver, cirrhosis and possible liver failure. Chronic liver 
damage has been estimated as occurring in as many as 40-50% of people with 
Hepatitis C (English, 1997; Zuckerman, 1989). The proportion of serious health 
difficulties resulting from HCV and potentially presenting to the health service will 
therefore, be high.
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2. HCV Prevalence among Injecting Drug Users:
Table 1 provides a review of recent research conducted in relation to HCV 
prevalence among IDU’s. It outlines the prevalence statistics from each study and 
highlights the factors which have been linked with virus transmission. Although the 
majority of research has been conducted in America and Australia, British and 
European studies are now also beginning to emerge.
Insert Table 1 here
It is clear from the literature that HCV is now affecting injecting drug users on a 
much larger scale than the HTV epidemic. Almost all of the studies document HCV 
antibody among IDU’s to be greater than 50%. Within the UK, average prevalence is 
estimated at 60% (Waller & Holmes, 1995), although infection rates seem to be 
particularly high within London and Glasgow where 71% and 77% prevalence has 
been documented respectively (Waller & Holmes, 1995; Goldberg et al 1998).
A number of factors are consistently linked with HCV status within the literature. 
These include duration andfrequency o f  injecting (Crofts et al, 1993), and co- 
infection with other viruses (Patti et al, 1993; Van Ameijden et al, 1993; Van Beek et 
al, 1994; Beil et al, 1990). Drug users who have longer injecting histories and those 
who inject most frequently are more likely to contract HCV. This may reflect the 
cumulative frequency of occasions during which the user has potentially been 
exposed to the virus. Alternatively, co-infection with HTV and Hepatitis B may 
depict high overall levels of risk-taking behaviour within certain individuals.
Research also indicates that the majority of HCV transmission occurs within the first 
6 years of injecting (Garfein et al, 1996). It is a cause of concern however, that the 
virus has also been found amongst recent onset injectors (Robinson et al, 1995; 
Carruthers & Loxley, 1995; Lamden et al, 1998). In one study, (Garfein et al, 1996) 
64.7% of IDU’s had contracted HCV within the first year of transition to injecting. 
This indicates that infection may occur almost immediately within the injecting 
history and requires that prevention strategies be targeted to initial stages of injecting 
and at those who may be at risk of commencing injecting.
There are however, a number of methodological difficulties within the current 
research. The majority of studies have been conducted with self-selected, treatment 
samples which are unlikely to be representative of the IDU population as a whole. 
The high level of variation between studies in relation to HCV prevalence is also 
difficult to explain. In order to develop a clearer picture of prevalence therefore, 
random sampling of IDU’s from both treatment and community populations is 
needed. Comparison of the injecting practices between areas where high and low 
levels of prevalence have been documented may also help clarify virus transmission.
3. HCV Transmission among IDU’s:
It is clear that transmission of HCV is occurring on a wide-scale among EDU’s. A 
number of factors are thought to account for the continued high incidence of the 
virus among this population. Like HTV, HCV is contracted through bodily fluids, 
particularly blood-blood contact. Unsafe injecting practices are therefore thought to 
be the most usual transmission route. This includes sharing un-sterilised syringes,
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and other injection paraphernalia including spoons, filters and rinsing water (Renton 
& Main, 1996). Although IDU’s have reduced needle sharing risks in response to 
HIV, many continue to share other injection paraphernalia (Gossop et al, 1997; 
Strathdee et al, 1997). As HCV is believed to be transmitted more easily than HTV 
through sharing injecting equipment (Garfein et al, 1996; Wodack & Crofts, 1996) 
this continues to place IDU’s at risk. Inadequate sterilisation of injecting equipment 
has also been highlighted as a possible HCV transmission route (Strathdee et al, 
1997). The sterilisation recommendations for HTV are not adequate to protect 
against HCV (Bodsworth, 1994; McNeilly, 1996). Despite cleaning equipment 
therefore, drug users who are unaware of this may be inadvertently infecting 
themselves.
Research also suggests that HCV may be contracted through household transmission 
routes (e.g. blood spills, sharing a toothbrush/razor) (Renton & Main, 1996) and to a 
lesser extent through unprotected sexual intercourse (Tor et al, 1990). There is 
therefore a potential spread of HCV, as with HIV to the non-DDU population. This 
possibility is concerning as many studies indicate that IDU’s have not readily 
reduced sexual risk behaviour (Hart et al, 1989; Needle et al, 1994; Rhodes & 
Stimpson, 1993; Des Jarlais, 1992; Stimpson, 1991). That the incidence of HCV 
remains negligible among the partners and families of infected IDU’s (Tedder et al, 
1991; Melbye et al 1990; Bresters et al, 1993) however, suggests that these 
transmission routes may be less effective.
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In light of these findings, it is necessary for research to assess not only syringe 
sharing risks among IDU’s but to extend methodology to include sharing of all kinds 
, of injecting paraphernalia and household and sexual transmission. IDU’s levels of 
awareness about HCV and regarding the sterilisation procedures required to protect 
against it should also be investigated. Subsequently, harm-reduction strategies must 
be extended to include information about the additional risks of sharing all kinds of 
injecting equipment and to advise IDU’s regarding general HCV prevention.
Part Two:
Hepatitis C Harm Reduction Strategies:
With the absence of a cure or vaccination for HCV, control of the virus must 
currently be attempted through the prevention o f  risk behaviours. As HIV research 
has already addressed the issue of behavioural change within IDU’s, it is possible 
that some existing theories may also be applicable to HCV. The present review 
focuses upon educational and psychosocial approaches to HCV prevention. The 
impact of medical interventions such as Methadone Maintenance is therefore not 
addressed.
1. HCV Awareness among IDU’s:
HIV interventions initially attempted to reduce risk behaviours by increasing 
awareness of the disease. This involved the development of media/information 
campaigns (Robertson et al, 1988) and group educational programmes (McCusker et 
al, 1992). Although research outcomes initially demonstrated reduced injecting and 
sexual,risk behaviour in response to awareness about HTV (des Jarlais, 1985, 1992;
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Selwyn et al, 1987; Neagius et al, 1990; Stimson, 1991), failure to observe a 
relationship between HIV information and behavioural change was also frequently 
reported (Friedman et al, 1992, 1997; Stimson, 1988; Des Jarlais, 1992). Despite 
awareness being necessary therefore, to allow those at risk to contemplate responses, 
the association between information and risk reduction is often weak.
Few studies have been undertaken to assess EDU’s level of awareness in relation to 
Hepatitis C. Studies which have addressed this issue have found that general levels 
of awareness concerning the virus are high (Carruthers & Loxley, 1995; current 
authors, 1999). IDU’s also correctly perceive themselves as being at greater risk of 
contracting HCV in comparison with HTV (Carruthers & Loxley, 1997). However, 
specific knowledge of HCV transmission, symptoms and treatment has been 
described as “barely adequate” (Carruthers & Loxley, 1995). Recent research by the 
present authors (1999) also suggests that IDU’s lack knowledge regarding the risks 
associated with sharing injecting paraphernalia, and that few are aware of the 
sterilisation procedures necessary to protect against HCV. Lack of information 
regarding effective HCV prevention may be a crucial factor in terms of continuing 
transmission.
In conclusion, although general awareness of HCV is high among IDU’s, there is a 
need for interventions to focus upon increasing specific knowledge regarding disease 
transmission and prevention. Findings from HIV research suggest that it is initially 
important to elicit gaps in knowledge before tailoring interventions to meet 
individual groups needs (Fisher & Fisher, 1992). This may therefore be an
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appropriate aim of localised HCV research. Although information about the virus is 
necessary to enable IDU’s to protect themselves, evidence from HIV research 
suggest that it is unlikely that an increase in knowledge alone shall be sufficient to 
instigate or maintain widespread behavioural change.
2. Self-efficacv:
Bandura’s theory of “self-efficacy” (1977) has become a widely applied construct 
within the addiction field. It has also formed part of some authors models of HTV 
Risk Behaviour change (Fisher & Fisher, 1992). Self-efficacy describes a person’s 
perception of the level of control which they have over their behaviour; high self- 
efficacy beliefs reflecting increased confidence regarding behavioural control. High 
levels of self-efficacy are also thought to motivate a person to exert effort when 
faced with a challenge, whilst low levels may result in capitulation. In relation to 
injecting drug users therefore, those with high levels of self-efficacy regarding harm 
reduction may be more inclined to resist risk taking.
Self-efficacy can be developed from both mastery and by vicarious learning. 
Therefore, within treatment, it is often closely linked with the development of 
behavioural skills. Consequently interventions which aim to reduce IDU’s risk 
behaviours are also usually increasing their self-efficacy with regards harm 
reduction.
In relation to HIV prevention, a number of studies have demonstrated an association 
between IDU’s self-efficacy beliefs and risk behaviour. In terms of sexual risk
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behaviour, Gibson et al (1988) found that IDU’s with high levels of self-efficacy 
regarding HIV prevention were more likely to insist on condom use with their 
partners. Self-efficacy beliefs among IDU’s have also been linked with safer 
injection practices including both the intention to use sterilised needles (.35) and 
reported clean needle usage (.46) (Kok et al, 1991).
Research has not yet addressed the question of whether a similar association exists 
between IDU’s self-efficacy beliefs regarding Hepatitis C prevention and risk 
behaviour. If so, self-efficacy may be utilised as an important variable and measure 
by clinicians during treatment. Increasing self-efficacy with regards HCV prevention 
would include developing IDU’s abilities to resist sharing injection paraphernalia 
and increasing their confidence in relation to effective sterilisation.
Whether increases in IDU’s self-efficacy regarding HCV prevention would reduce 
virus prevalence is however, questionable. HCV may be spread too easily for small 
increases in individuals’ self-efficacy to make an impact. Widespread behavioural 
change among EDU sub-cultures may alternatively, be necessary. It is also likely that 
risk taking is influenced by more than low levels of self-efficacy. Situational and 
interpersonal factors including the availability of sterile injecting equipment and peer 
group attitudes and response to HCV are also likely to be important.
3. Peer-group Influence:
In response to these individualistic perspectives of risk taking, a number of authors 
have argued for a more comprehensive view of risk behaviour which incorporates 
social influence processes (Stimson, 1988; Connors, 1992; Gilles & Carballo, 1990;
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Rhodes et al, 1996). In line with this approach, Fisher & Fisher (1992) developed a 
model of HIV risk behaviour change which describes the possible influence of peer 
groups upon risk behaviour. They hypothesised that group pressures encourage drug 
users to practise either HIV risk or HIV prevention behaviour in concordance with 
group norms. This is thought to occur through a number of psychosocial processes 
including modelling, persuasion, conformity effects and fear of ostracism (Fisher & 
Fisher, 1992).
A number of studies have substantiated the existence of a positive association 
between IDU’s risk behaviour and that of their peer group [Tross et al, 1989; Des 
Jarlais* 1985; Magura et al, 1989). Peer group influence has also been found to be 
important in terms of both initiation to injecting and undertaking harm reduction 
(Friedman, 1987). Research attempting to initiate community responses to risk 
reduction (Neaigus, 1994) has also demonstrated success in relation to reduced 
sharing of injecting equipment and increased efficacy of equipment sterilisation. 
Whilst being designed to reduce HIV risk behaviour, this intervention also succeeded 
in affecting some of the behavioural change required for Hepatitis C prevention.
From this literature, it can be expected that peer groups may similarly encourage 
either Hepatitis C prevention behaviour or Hepatitis C risk behaviour, dependent 
upon group norms. Further research is needed to describe the attitudes and response 
of subcultures of drug users to HCV. The influence of peer groups upon Hepatitis C 
risk behaviour and harm reduction also needs to be assessed. Following firom this, it
33
may be useful to develop outreach programmes aimed at promoting HCV prevention 
within drug user community groups.
Can HIV research be applied to HCV?
This review has suggested that some elements of HIV research may usefully act as a 
guide for those undertaking future HCV prevention work with IDU’s. This is 
indicated due to the many similarities between HTV and HCV for the IDU 
(transmission routes/lack of an effective treatment) making it a reasonable 
proposition that research in one field may be applicable in part to the other.
However, it would be naive to assume that all interventions which have proven 
useful in terms of HIV shall do so in terms of HCV. A study by Crofts (1997) 
highlights this difficulty. Crofts (1997) found that Methadone Maintenance 
Treatment although useful in reducing transmission rates of HIV among injecting 
drug users made no similar impact upon transmission rates of HCV. Crofts 
explained this result in relation to the increased transmission rate of Hepatitis C 
compared with that of HIV. Similar difficulties have also been documented by 
Strathdee (1997) who found that despite implementation of a needle exchange in 
Vancouver, Hepatitis C prevalence among IDU’s rose to 88%.
There is therefore a need for theories and research to be applied directly to HCV and 
not simply applied from HIV. The usefulness of interventions needs to be 
determined empirically, through research and tailored specifically to address HCV 
prevention. At present research upon Hepatitis C prevention among IDU’s is sparse.
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A concerted effort is needed to reduce prevalence and to prevent the spread of 
Hepatitis C among IDU’s becoming endemic.
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MAJOR RESEARCH PROJECT PROPOSAL
Title: The Association between Injecting Drug Users* Knowledge, Self-efficacy 
Beliefs, Peer Group Norms and Hepatitis C Risk Behaviour.
Summary
The prevalence of the Hepatitis C virus (HCV) is now widespread among injecting drug 
users (IDU’s). Despite this, there is a lack of research into factors which may be 
important in terms of HCV risk behaviour and which may therefore guide prevention 
initiatives. The aim of the present study is to investigate the relationship between HCV 
risk behaviour and three factors which are often important determinants of risk 
behaviour - level of knowledge, self-efficacy beliefs and peer group norms. A 
structured questionnaire which assesses these variables in relation to HCV has been 
designed for use within the study. It is planned to interview 100 injecting drug users 
from both treatment and non-treatment samples. Participants for the study shall be 
recruited from treatment agencies and community outreach projects within the 
Lanarkshire area. It is expected that results from the study will provide information 
which is valuable to HCV prevention initiatives which are aimed at injecting drug users.
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Introduction
HCV is now recognized as an infection affecting drug users often with very serious 
consequences and on a greater scale than the HIV virus. Over half of those who develop 
acute Hepatitis C go on to develop chronic HCV and 40-50% of these people develop 
chronic liver disease. Most prevalence studies among IDU’s have found HCV antibody 
to be higher than 50% (Robinson et al 1995; Thomas et al 1995). Research indicates 
that up to 60% of IDU’s in the UK have HCV and this rate increases to over 70% in 
London and Glasgow (Waller & Holmes, 1995).
In the absence of an effective treatment for HCV, control must be attempted through the 
reduction of HCV risk behaviours. In addition to needle sharing, potential sources of 
transmission may include the indirect sharing of spoons used for preparing drug 
solutions, cookers, filters and rinsing water. Studies also report evidence of the sexual 
transmission of HCV although the rate of sexual transmission of the disease is generally 
agreed to be low (Tedder, 1991; Renton, 1996; Alter, 1991). Nevertheless, research 
indicates the potential for drug users to contribute to the spread of HCV through sexual 
risk behaviour. Crisp (1993) found that although IDU’s may adopt safe injection 
practices they still engaged in sexual risk behaviours which placed them at risk of 
developing both HIV and HCV.
Following from studies on HTV/Aids there is a vast research literature which identifies 
important determinants of behaviour change and which may usefully be applied to HCV.
Three important factors which have been discovered include knowledge, self-efficacy
beliefs and peer-group norms.
1. Knowledge can be an important prerequisite to behaviour change as “individuals 
must have developed an awareness of a disease before they can be expected to form 
responses to it” (Brunswick, 1996). It is widely accepted however that knowledge is 
not usually sufficient to create behaviour change.
2. Self-efficacy models measuring a persons sense of control over their behaviour 
(Bandura, 1992), have been successfully applied within addiction and HTV research. 
It has been found that high self-efficacy is significantly related to safer injection 
practices (Falck, 1995) and that it is important in terms of both the change and 
maintenance of Aids risk behaviours.
3. Additionally, research on injecting and sexual risk behaviours has indicated the need 
to move beyond individual factors to take account of the importance of the social 
networks within which risk behaviours occur. In line with this work research 
indicates that perceived peer norms are important and highly associated with the 
performance of Aids risk behaviours (Kelly, 1994; Fisher, 1988). In relation to HCV 
risk behaviour a person’s social network may therefore be either relatively consistent 
or inconsistent with the practice of risk behaviours and this may influence group 
members actions.
In summary therefore, there is an urgent need to control the continuing spread of HCV 
within the drug using population. As with HIV/Aids there is presently no vaccine or 
effective treatment for HCV and therefore the main way of reducing transmission is 
through behaviour change. The objective of the present study is to test the applicability 
of some determinants of Aids risk behaviour change to HCV risk behaviour. The 
importance of injecting drug users level of knowledge, self -efficacy beliefs and peer 
norms will therefore be measured in relation to their current risk behaviours.
Research Aims
The aim of the present study is to investigate the relationship between injecting drug 
users’ level of knowledge, self efficacy beliefs and peer norms in relation to HCV risk 
behaviours. As a result is hoped to determine whether some of the research which has 
outlined the effective factors relating to HTV/Aids risk behaviour change may usefully 
be applied to work on the HCV virus. In conducting the study it is therefore, expected 
to provide information which is valuable to HCV prevention initiatives aimed at IDU’s.
Research Hypotheses
l. It is hypothesized that level of knowledge about HCV will be associated with level of 
risk behaviour -  those who have higher levels of knowledge are expected to engage 
in less risk behaviour than those who have lower knowledge levels.
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2. It is hypothesized that self-efficacy beliefs will be associated with injecting risk 
behaviour. It is expected that IDU’s who have higher levels of self-efficacy in 
relation to refraining from HCV risk behaviour shall engage in less risk behaviour 
than those who have low self-efficacy beliefs.
3. It is hypothesized that level of injecting risk behaviour will be associated with peer 
group risk behaviour/attitude to HCV. It is expected that higher levels of risk 
behaviour will be related to increased peer risk attitudes/behaviour.
Research Method and Design
Pilot Study
A pilot study will be carried out to improve the design and to test the validity of the 
questionnaire. The aim is to have 10 questionnaires completed at this stage.
Desim:
Similar research undertaken in relation to HTV/Aids has relied upon convenience 
sampling from treatment centers. However, research indicates that information gathered 
solely from treatment samples provides an unrepresentative account of the level of risk 
behaviour evident in the drug injecting population (Rosenstock, 1988). In the present 
study therefore it is planned to gather information from both in-treatment samples and 
from injecting drug users who are not currently involved with treatment agencies. This 
shall be undertaken through contact with a number of treatment services and through 
contact with a variety of community outreach projects within the Lanarkshire area.
In terms of gathering information concerning previous risk behaviour, research indicates 
that it is useful to request information which is based on a specific time frame and that 
to improve reliability this should not exceed 1 year (Samuals, 1992). Questions 
regarding risk behaviour in the present study therefore, relate to the 6 months previous 
to interview.
Despite concerns, a variety of studies have demonstrated that injecting drug users 
provide relatively accurate self-report information (Samuals, 1992; Hammersiey, 1994). 
Self-report responses also provide the most practical way of obtaining information from 
large samples and are widely used in this field. The information collected in the study 
will therefore, be based upon participant self-report.
Information will be gathered by interviews undertaken using a structured questionnaire. 
Prior to interview, client confidentiality will be assured and participants shall be 
informed that their taking part will have no bearing upon any treatment which they are 
undertaking. Additionally, participants will have the option to decline to take part in or 
opt out of the study at any point during the interview.
The dependent variable in the present study is ‘risk behaviour’. This is measured by risk 
behaviour questions from the questionnaire. These questions are mainly presented on 
ordinal scales. The independent variables in the present study are knowledge, self- 
efficacy and peer group norms. These variables are also measured from the
questionnaire. An overall index of knowledge will be calculated by summing correct 
responses from the questionnaire. Questions relating to self-efficacy and peer group 
norms are presented on ordinal scales and overall scores will be calculated for each 
participant. Bivariate relationships between these variables will be tested followed by 
regression analysis to identify predictors of risk behaviour. The design of the study also 
involves comparison of these variables between groups (in treatment v’s not in 
treatment).
Participants:
Inclusion Criteria: Drug users who have injected within the previous 6 months.
The aim of the study is to sample 100 injecting drug users.
Measures:
A questionnaire which assesses IDU’s knowledge of HCV, peer norms, self-efficacy 
beliefs and recent risk behaviour has been designed (see Appendix 3). It may be altered 
in response to the outcome of the pilot study. Demographic information, drug history 
and HCV information (eg. Age, gender, length of injecting ‘career’ and current HCV 
status) has also been included as the literature suggests that it may have bearing upon the 
practice of risk behaviours.
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Data Analysis
Data wiil be collated and analysed using the Statistical Package for Social Sciences. 
Descriptive statistics will initially be undertaken. The design of the study involves 
comparison between groups (in treatment v’s not in treatment) which will involve t-tests 
if data is parametric. It is expected that the investigation of bivariate relationships 
between variables shall be measured using correlational analyses. In order to determine 
which, if any variables serve as predictors of risk behaviour, multivariate regression 
shall be undertaken. Additional factors which may influence the equation will be 
entered (e.g. age, length of injecting history, HCV status).
Practical Applications
It is expected that results from the study will have clear practical applications for both 
treatment agencies working with injecting drug users and in terms of HCV prevention 
initiatives. A general lack of knowledge about HCV may suggest the need for 
healthcare agencies to further promote information about HCV to drug users. If self- 
efficacy beliefs are influential, practitioners may wish to focus upon this factor during 
treatment programmes. Additionally, if peer group norms have a large influence on 
HCV risk behaviours, community outreach initiatives may wish to model and encourage 
HCV prevention behaviours within drug using groups.
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Ethical Approval
Ethical approval shall be sought from the Ethics Committee at Lanarkshire Health 
Board.
Timescale:
Literature Review }
Data Collection }
Data Analysis }
Final Written Presentation }
Expected Date o f Completion
01.09.98
31.05.99
31.06.99
31.07.99
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Abstract
Aims - To determine whether Hepatitis C knowledge, self-efficacy beliefs and peer 
group norms are associated with Hepatitis C risk behaviour among Injecting Drug 
Users (IDU’s). Design -  A correlational design was employed. The study also 
involved between-group analysis of IDU’s who were receiving treatment and not 
receiving treatment. Setting & Participants - Eighty-one IDU’s were recruited 
from Lanarkshire, Scotland. Fifty-eight were recruited from treatment agencies and 
twenty-three were recruited from a community sample by ‘snowballing techniques’. 
Measurement - A questionnaire was devised to assess Hepatitis C knowledge, 
current risk behaviour, self-efficacy and peer-group norms. Findings - IDU’s lack 
knowledge in relation to Hepatitis C prevention. Although few IDU’s reported 
sharing needles many still share injecting paraphernalia placing them at risk of 
Hepatitis C. Hepatitis C status and peer group norms were modestly predictive of 
injecting risk behaviour. Self-efficacy beliefs were moderately predictive of sexual 
risk behaviour. Conclusions - It is necessary to educate IDU’s regarding Hepatitis C 
prevention and the ongoing risks of sharing injecting paraphernalia. Community 
outreach interventions may be the most beneficial way of initiating a peer-based 
reduction in injecting risk behaviour.
Key W ords: Injecting Drug
Users, Hepatitis C.
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Introduction
Hepatitis C (HCV) is now recognised as being widespread among injecting drug 
users (IDU’s). Within the UK, average prevalence is estimated at 60%, although 
infection rates have been found to be higher within London and Glasgow where 71% 
and 77% prevalence have been documented respectively (Waller & Holmes, 1995; 
Goldberg et al 1998).
Unsafe injecting practices, including sharing syringes and other injecting 
paraphernalia (spoons, filters, rinsing water) are thought to account for continuing 
incidence of HCV (Renton & Main, 1996). Research has also linked transmission to 
duration and frequency of injecting (Crofts et al, 1993) and
‘frontloading/backloading’ practices 1 (Stark et al, 1996). Although it is now thought 
to be less likely that HCV can be contracted through unprotected sexual intercourse 
(Tedder et al, 1991; Melbye et al, 1990; Bresters et al, 1993), ‘household' 
transmission (e.g. blood spills, sharing razors/toothbrush) remains probable placing 
the partners and families of EDU's at a continued risk (Peano et al, 1992).
As there is currently no cure or vaccine for HCV, virus control must be attempted by 
the prevention of risk behaviour. Research focusing upon IDU's understanding of 
and response to HCV is therefore, now being undertaken. Initial outcomes suggest 
that although awareness of the virus is high, specific knowledge regarding HCV 
transmission, symptoms and treatment may be inadequate (Carruthers & Loxley,
1 Frontloading’ and ‘Backloading’ describe methods for dividing a drug solution by passing it from 
one syringe to another (Grund et al, 1990).
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1995). Lack of information may therefore be important in relation to continuing 
transmission.
“Self-efficacy’ (Bandura, 1977), reflecting perceived control over behaviour and 
peer group risk behaviour have also been recognised as important in relation to harm 
reduction among IDU’s. Kok et al (1991) found that increased self-efficacy was 
positively correlated with both intention to use sterilised needles (.35) and reported 
clean needle usage (.46). Peer-group behaviour has also been found to encourage 
IDU’s to engage in either risk or preventative action dependent upon group norms 
(Fisher & Fisher, 1992; Tross et al, 1989; Des Jarlais, 1985; Magura et al 1989). 
Although little is currently known about the influence of self-efficacy and peer-group 
norms in relation to HCV prevention, they may be expected to function in a similar 
way.
The current study describes a survey of IDU’s from Lanarkshire, Scotland. Its aim 
was to assess knowledge regarding HCV, current risk behaviour, self-efficacy in 
relation to HCV prevention and peer group norms. It was hypothesised that 
increased knowledge/self-efficacy and lower levels of peer risk behaviour would be 
associated with lower levels of IDU risk behaviour (injecting/sexual). The study also 
included a comparison between “in-treatment” and “not in treatment” IDU’s. It was 
hypothesised that IDU’s who were not receiving treatment would be more likely to 
engage in risk behaviour than those who were receiving treatment (Hunter &
Stimson, 1998). As self-report information from IDU’s has been shown to be
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relatively reliable (Samuals, 1992; Hammersley, 1992), data was obtained for the 
study using this method.
Method
1. Participants:
In total, eighty-one injecting drug users were interviewed. Fifty-eight were recruited 
from addiction agencies (methadone clinics/counselling) and comprised the in­
treatment sample of IDU’s. Twenty-three were recruited by a combination of 
methods including the snowballing technique’2, attendance at local needle-exchanges 
and from waiting lists for addiction services. These participants were not receiving 
medical treatment or counselling for their drug use at the time of study and 
comprised the ‘not in treatment’ sample of IDU’s. All participants who agreed to 
take part in the study completed the interview/questionnaire. Only two IDU’s 
refused to take part in the study stating that they did not have time to do so.
2. Measures:
Hepatitis C Questionnaire - A questionnaire was developed by the principal 
researcher in order to assess participants’ Hepatitis C knowledge, self-efficacy 
beliefs, risk behaviour and peer attitudes/behaviour (Appendix 3). Questionnaires 
have previously been designed to assess these variables in relation to HIV (Neagius 
et al, 1990; Kok et at, 1991; Magura et al, 1989), although none known to the author 
have been developed relating specifically to HCV. The questionnaire was . 
constructed as follows -
2 A technique where drug users who can be recruited introduce the researcher to other drug users who they are in 
contact with. A well-established method within drug research (Biemacki & Waldorf; 1981; Morrison, 1988).
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Part 1: Demographic and Hepatitis C Information -  This section of the questionnaire 
inquired about demographic information, Hepatitis C risk perception and perception 
of the seriousness of the virus in relation to other risks of drug use. It also asked 
about Hepatitis C status (if known) and acquaintance with others who have the virus.
Part 2: Knowledge -  This scale contained sixteen questions and assessed knowledge 
about Hepatitis C. It included sub-scales pertaining to knowledge about Hepatitis C 
symptoms, treatment, transmission routes (injecting/household/sexual) and 
prevention (sterilisation). Questions were developed from information from the 
Hepatitis C Handbook (Dolan, 1994) and care was taken not to include questions 
which would require medical or specialist expertise. Participants answered each 
question by stating whether they thought it was “true” or “false”. An overall 
“knowledge score” was calculated for each participant from correct responses on this 
measure, alongside scores for each knowledge sub-scale.
Part 3: Risk Behaviour - Containing seventeen items, this part of the questionnaire 
was designed to assess differing aspects of IDU’s HCV risk behaviour. As research 
indicates that it is useful to request information about risk behaviour based upon a 
specific time-frame and not exceeding 1 year (Samuals, 1992), questions related to 
the 6 months prior to interview. Questions included age of initiation to injecting, 
duration of injecting history, current frequency of injecting and participation in 
“ffontloading” and “backloading”. These variables have been found to be associated 
with positive Hepatitis C status within the literature (Lamden et al, 1998; Serfaty et 
al, 1997; Van Beek, 1995). Questions also inquired about frequency of borrowing,
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lending and cleaning used injecting equipment and paraphernalia (e.g. 
spoons/filters), and assessed sexual risk behaviour. Most risk behaviour questions 
were designed on a four-point ordinal scale ranging from “Not Often” to “Very 
Often”. Client responses were scored in relation to individual risk questions and sub­
scales were developed by totalling ordinal measures of injecting and sexual risk 
behaviour.
Part 4: Peer-group Norms -  This section of the questionnaire contained ten items and 
was designed to assess peer attitudes and behaviour (peer-norms) in relation to 
Hepatitis C risk-taking. Questions were developed in accordance with 
recommendations for measurement of peer-group norms (Connor & Norman, 1996) 
and involved items relating to social pressure, peer risk behaviour, peer approval and 
peer disapproval. Responses were categorised on a five point ordinal scale. In 
addition to scores for individual items an overall “peer-norm” score was calculated 
by summing ordinal ratings for different HCV risks.
Part 5: Self-efficacy Beliefs -  This scale was designed to assess participant’s self- 
efficacy in relation to HCV prevention and was developed in accordance with 
recommendations for measurement of self-efficacy (Connor & Norman, 1996). It 
was constructed similarly to part four of the questionnaire and produced self-efficacy 
ratings for individual questions and an overall self-efficacy rating.
Cronbachs alphas for the constructs used to operationalise each dimension of the 
questionnaire are presented in Appendix 4. Analysis indicated that sexual risk
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questions are best conceived of as a separate index of risk behaviour. Alpha ratings 
for “peer-group norms” and “injecting risk behaviours” were slightly below 
recommended levels (Clark & Watson, 1995) indicating that these scales may benefit 
from being adapted for future research.
3. Procedure -
Pilot Study -  In order to pilot the questionnaire ten participants were initially 
interviewed. At this time some changes to the questionnaire design were made 
(Appendix 4). As major alterations were not required, completed questionnaires 
from these participants were included within the final sample.
Study - After being introduced to the researcher, IDU’s were given verbal and 
written information about the study, its aims and requirements (Appendix 3). Study 
inclusion criteria involved having injected at least once within the six months prior to 
interview. Participants were assured of confidentiality and following agreement to 
comply completed a research consent form (Appendix 3). They then undertook the 
fifteen-twenty minute semi-structured interview with the principal researcher and 
completed the questionnaire.
Results
Demographic information is presented in Table 1. In total, eighty-one IDU’s were 
interviewed, fifty-eight of whom were in treatment and twenty-three who were not 
receiving treatment at the time of study. Seventy-three of those interviewed were 
male whilst nine were female. The mean age of participants was twenty-eight (range
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18-45). Most were unemployed (91%), single (51%) and had attained no school 
qualifications (49%). Six percent reported that they were ‘homeless’ at the time of 
study.
Insert Table 1 here
All of those who were interviewed stated that they were aware of Hepatitis C. Sixty 
percent defined the virus as “very serious” compared with the other risks involved in 
drug use. Only 5% considered HCV to be “not-serious” Risk perception varied 
among participants with 48% stating that it was “very unlikely” they would develop 
HCV, 20% stating it was “likely” and 32% stating it was “very likely”. Seventy three 
percent of those interviewed knew someone who had HCV and 42% of the sample 
had themselves been tested. Of those tested, 38% reported being HCV positive. 
Being acquainted with others who. have the virus was associated with diagnosis of 
HCV (r=.31; p< .001), as was duration of injecting history (r=0.19; p< .05), (Table 
2).
Insert Table 2 here
Predictors o f Injecting and Sexual Risk Behaviour - In order to test the main 
hypothesis, bivariate relationships between injecting/'sexual risk behaviour, and 
knowledge, self-efficacy and peer-group norms were examined using Kendall’s Tau- 
b correlation (Table 2). Outcome from this analysis indicated that peer injecting risk 
behaviour was modestly associated with injecting risk behaviour (r=0.21, p<0.05). 
Sexual risk behaviour was found to be negatively associated with sexual risk self­
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efficacy (r=-0.54, p<0.001), and was positively associated with peer sexual risk 
behaviour (r=0.29, p<0.01).
Multiple stepwise regression was also conducted in order to determine any predictors 
of injecting and sexual risk behaviour. Age, duration of injecting history, risk 
perception and HCV status were also included within this analysis. The resulting 
model identified HCV status and peer risk behaviour as predictors of IDU risk 
behaviour (r2= 16.8, Adj. r2=14.7, p<0.05), (Table 3). These factors accounted for 
15% of the variance. In relation to sexual risk behaviour, self-efficacy was identified 
as the single predictor within the model (r2= 0.23, Adj r2 = 31.0, p<0.001), 
accounting for 31% of the variance (Table 3).
Insert Table 3 here
HCV Knowledge -  Although knowledge of HCV was high overall (mean correct 
responses=l 1), incorrect responses were frequently given in relation to Hepatitis C 
prevention questions [mean correct responses = 2 (50%)]. Thirty-two percent of 
participants also underestimated the consequences of HCV believing treatment to be 
‘very effective’ and that they could be vaccinated against the virus. There were no 
significant differences between IDU’s who were receiving and not receiving 
treatment in relation to HCV knowledge (Table 4).
Insert Table 4 here
Risk Behaviour - The mean age of initiation of injecting amongst the sample was 
twenty-three, and mean duration of injecting was five years (see Table 5).
Participants who were receiving treatment were found to have a significantly longer
injecting history than those who were not receiving treatment (p<0.01) but reported 
injecting significantly less frequently (p<0.05) (Figure 1).
Insert Table 5 & Figure 1 here
Most participants reported that they had not borrowed used needles in the six months 
prior to interview (Figure 2). Sharing injecting paraphernalia (e.g. spoons/filters) was 
however, frequently reported (mean no. of occasions =33, median =2). IDU’s who 
were not receiving treatment reported significantly higher levels of sharing injecting 
paraphernalia than those who were in-treatment (p<0.01) (Figure 3). Many IDU’s 
(39%) who shared paraphernalia reported that they did “not often” clean it before 
use. Only seven percent sterilised paraphernalia with bleach, (the recommended 
procedure to prevent against HCV).
Insert Figures 2 & 3 here
High levels of sexual risk behaviour were also reported within the current study 
(Figure 4). Nineteen percent of IDU’s reported having sex “often” without using a 
condom and 24% “very often”.
Insert Figure 4 here
Self-efficacy -  There were no statistical differences between IDU’s who were 
receiving treatment and those who were not receiving treatment in relation to self- 
efficacy (Table 4). High levels of self-efficacy were reported in response to most 
risk behaviour questions (see Appendix 4). Lower levels of self-efficacy were
3 Responses o f ‘Completely untrue’ and ‘Mainly untrue’.
documented by some IDU’s however, in relation to sexual risk behaviour (33%) and 
sterilisation of injecting paraphernalia (32%).
Peer-group Norms -  There was a large degree of variability between IDU’s 
responses in relation to peer norm questions (s.d =6.0) (see Appendix 4), suggesting 
differences in the attitudesfaehaviours of peer groups. No statistical differences were 
found between IDU’s who were receiving treatment and those who were not 
receiving treatment in relation to peer group norms (Table 4). ’Peer risk behaviour’ 
was most frequently reported in relation to engaging in unprotected sexual 
intercourse (76%), sterilisation of used syringes (75%) and of paraphernalia (51%). 
Most IDU’s (74%) reported that peers did not put them under social pressure to use 
borrowed injecting equipment, although 60% said that they felt under some degree of 
pressure to lend equipment. A high percentage of IDU’s (40%) reported that peers 
would not ‘disapprove’ if they re-used equipment without cleaning it.
Discussion
Results from the current study suggest that, although IDU’s are aware of HCV and 
perceive it to be a serious problem, continued injecting risk behaviour places many at 
risk. Few participants reported sharing needles/syringes. However, as documented 
within other studies (Gossop et al, 1997; Strathdee et al, 1997), most acknowledged 
sharing injecting paraphernalia (spoons/filters). Failure to modify these risk 
behaviours suggests that many IDU’s may be unaware of the substantive risk of 
contracting HCV through shared injecting paraphernalia. It is also of concern that 
reported methods of sterilising injecting equipment were often inadequate to protect
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against HCV (bleach was not commonly used). Outcome from the HCV knowledge 
questionnaire confirmed that many IDU’s lacked accurate information regarding 
HCV prevention. This finding concurs with previous research (Carruthers & 
Loxley, 1997) and indicates the necessity for information campaigns to focus upon 
improving specific knowledge in relation to HCV prevention.
HCV status and peer injecting risk behaviour were found to be modestly predictive 
of injecting risk behaviour. This finding adds some credence to the argument that 
IDU’s risk behaviour concurs with that of peers (Fisher & Fisher, 1992). It also 
suggests that IDU’s who have HCV may be more inclined to reduce injecting risk 
behaviour. Both identified variables however, only accounted for a small proportion 
of the total variance and therefore have limited explanatory power. Other factors, 
which were not assessed, are also likely to be important in relation to injecting risk 
behaviour including needle-exchange provision within the area.
Findings did not substantiate the hypotheses that level of knowledge and self- 
efficacy beliefs would also be associated with injecting risk behaviour. Most IDU’s 
reported high levels of self-efficacy and had a high level of knowledge despite 
engaging in risk behaviour. This concurs with outcome from HTV research 
suggesting that knowledge alone is unlikely to instigate behavioural change 
(Friedman et al, 1992,1997). That many IDU’s had high levels of self-efficacy 
regarding future harm reduction despite currently engaging in risk behaviour is 
perplexing. However, responses may depict their intention to reduce injecting risks 
rather than being representative of their current behaviour.
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Sexual risk self-efficacy was moderately predictive o f sexual risk behaviour. These 
variables were also strongly negatively correlated, as initially hypothesised. This 
indicates that EDU’s who have high levels of sexual risk self-efficacy are less likely 
to have sexual intercourse without using a condom. In contrast with self-efficacy for 
injecting risk behaviours, many EDU’s within the study reported low levels of sexual 
risk self-efficacy. A high proportion also reported engaging in frequent sexual risk 
behaviour. These findings concur with outcomes from previous research (Needle et 
al, 1994; Rhodes & Stimpson, 1993; Des Jarlais et al, 1992) indicating that IDU’s 
have not readily reduced sexual risk behaviour, and suggesting that they are not 
confident about their propensity to do so. Although most research suggests that 
HCV is infrequently transmitted sexually (Tedder et al, 1991; Melbye et al, 1989; 
Bresters et al, 1985), sexual risk behaviour continues to constitute a risk in relation to 
HIV. These results are concerning therefore, and suggest that harm reduction 
campaigns should continue to emphasise the importance of practising safe sex to 
IDU’s and their partners.
The hypothesised between treatment group differences in relation to injecting risk 
behaviour were mainly supported. IDU’s who were receiving treatment reported 
injecting, and sharing paraphernalia significantly less frequently than those who were 
not receiving treatment. As most of the EDU’s who were receiving treatment were 
being prescribed methadone, this finding adds strength to existing evidence 
indicating that methadone maintenance reduces both injecting drug use, and injecting 
risk behaviour (Ward et al, 1992; Caplehom & Ross, 1995).
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Thirty-eight percent of participants who had been tested for HCV reported to the 
researcher that they were HCV positive. This percentage is low in relation to 
outcomes from prevalence studies which commonly document 60%-80% HCV 
prevalence (Waller & Holmes, 1995; Lamden, 1998, Goldberg, 1998). It bears 
similarity however, to outcome of a prevalence study (33%) conducted within the 
same locality during the previous year (Taylor & Farquhar, 1998).
In concurrence with findings from other HCV research, positive HCV status was 
associated with duration of injecting history (Lamden, 1998; Smyth, 1998; Van den 
Hoek, 1990; Carruthers & Loxley, 1997). That IDU’s who have a longer injecting 
history are more likely to have HCV, may reflect the cumulative frequency of 
occasions during which they have potentially been exposed to the virus. HCV status 
was also associated with knowing someone who has the virus, possibly indicating 
peer transmission. Unlike other studies, HCV status was not found to be associated 
with frequency of injecting, frequency of borrowing used needles or 
frontloading/backloading (Stark, 1996). As the current study was not primarily 
designed to measure transmission, and most of the IDU’s interviewed were unaware 
of their HCV status, it is likely it was not sensitive enough to detect these 
relationships.
Low levels of self-efficacy and increased peer-group risk behaviour were most 
frequently reported in relation to engaging in sexual risk behaviour and sterilisation 
of injecting equipment. This suggests that IDU’s may be less confidant regarding 
reducing these kinds of risk and indicates that peer norms could be reinforcing them.
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Many IDU’s also reported low levels of peer disapproval in relation to use of un­
sterilised injecting equipment. Lack of peer disapproval in response to risk 
behaviours may be indirectly reinforcing their practice. Community outreach 
interventions may therefore be necessary in order to modify both the attitudes and 
behaviour of IDU’s and their peer-groups in relation to adequate sterilisation of used 
injecting equipment. Widespread behavioural change within the IDU community is 
also required in order to reduce sharing of injecting paraphernalia. It is possible that 
modification of these kinds of risk behaviour will reduce transmission of HCV.
Methodological difficulties within the current study include its reliance on self-report 
information and omission of objective measures. Although research suggests that 
self-report information from IDU’s is relatively reliable (Samuals, 1992;
Hammersley, 1992), many participants were interviewed following a medical 
appointment and may have been wary regarding the confidentiality of their 
responses. This could have caused them to under-report injecting risk behaviours.
As sharing injecting equipment is also perceived as being a stigmatised activity 
(Hunter & Stimson, 1998), some IDU’s may not have been willing to fully disclose 
the extent of their risk behaviour. These factors make it difficult to determine the 
accuracy of the information gathered during the study. It may therefore, have been 
useful to include objective measures of drug use (e.g. urine samples/medical records) 
in order to validate some aspects of the information reported.
The study also included a small number of female participants resulting in findings 
being unlikely to generalise to female IDU’s. The proportion of female IDU’s
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recruited (10% of the sample) is unlikely to reflect actual differences in the 
percentages of female and male IDU’s. Alternatively, it is recognised that females 
may be less likely to seek treatment and to present to services for illicit drug use, due 
to both stigma and fears that children may be taken into care. Future research should 
therefore, try to identify ways of increasing recruitment of female IDU’s.
The study involved development of a questionnaire designed to measure, in relation 
to HCV, some of the psychosocial predictors of HIV risk behaviour. Although the 
validity and reliability of this scale remains in question, the authors hope to further 
develop and standardise it within future research.
Conclusions and recommendations from the current study, include the necessity for 
interventions to increase IDU’s understanding of HCV prevention and the 
transmission risks involved in sharing injecting paraphernalia. Findings did not 
wholly support the original hypothesis that HCV risk behaviour would be associated 
with level of knowledge, self-efficacy beliefs and peer-group norms. Hepatitis C 
status and peer-group norms were however, modestly predictive of HCV risk 
behaviour. Taking account of the social context of injecting risk behaviour, 
community outreach interventions may therefore, prove to be the most beneficial 
way of initiating risk behaviour change. As findings suggest that low levels of peer 
pressure to refrain from HCV risk behaviours are currently operating however, it is 
likely that this will require a concerted effort on behalf of treatment agencies.
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Table 1: Demographic Information
Variable In-treatment
N=58
Out of treatment
N=23
Total Sample 
N=81
Age
Mean (yrs) 28 28 28
Range (yrs) 25 (18-43) 26 (19-45) 27 (18-45)
Gender
Males 90% 91% 90%
Females 10% 9% 10%
Age Left School
Mean (yrs) 16 16 16
Marital Status
Single 59% 39% 53%
Married 10% 30.5% 16%
Other > 31% 30.5% 31%
Accommodation
House/Flat 93% 96% 94%
Homeless 7% 4% 6%
Qualifications
None 48% 52% 49%
O/Standard Grades 34% 40% 36%
Highers 7% 4% 6%
Further Education 10% 4% 9%
Occupational Status
Employed 3% 9% 6%
Unemployed 91% 91% 91%
Further Education 5% 0% 3%
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Table 2: Kendall’s Tau-b Correlations: *
Variables: No. of
Respondents
Kendall’s Tau-b Significance
Levet
1. Injecting Risk Behaviour 
& Knowledge 81 -0.07 non-significant
2. Injecting Risk Behaviour 
& Self Efficacy 81 -0.13 non-significant
3. Injecting Risk Behaviour 
& Peer Norms U 0.21 p<0.Q01
4. Positive HCV Status & 
Friends with HCV
81 031 p<0.001
5. Positive HCV Status & 
Duration of Injecting 
History
81 0.19 p<0.05
6. Sexual Risk Behaviour and 
Sexual Risk Self-efficacy 81 -0.54 p<0.001
7. Sexual Risk Behaviour and 
Peer Sexual Risk Behaviour U 0.29 p<0.01
* Two-tailed correlation’s were selected as associations between the variable were not predicted prior 
to data analysis.
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Table 3: Regression Analyses (Stepwise) for Injecting and Sexual Risk
Behaviour:
Outcome Variable F ratio P R2 Adj R2 Explanatory 
Variables (P)
i. Injecting Risk 
Behaviour
7.87 0.005 16.8 14.7 Hepatitis C 
Positive (0.005)
Increased Peer 
Group Risk 
Behaviour (0.005)
2. Sexual Risk 
Behaviour
36.9 0.001 32.8 31.0 Lower Self- 
Efficacy (0.001)
1. txcluded Variables: Age, Treatment Group, Risk Perception, Injecting History, 
Acquaintances with Hepatitis C, Self-efficacy Beliefs and Hepatitis C Knowledge.
2. Excluded Variables: Age, Treatment Group, Hepatitis C Knowledge, Peer Sexual Risk 
Behaviour, Hepatitis C status.
Table 4: Mann Whitney U Analysis of Between Group Differences
Variable N Mean
Rank
Sum of 
Ranks
Mann 
Whitney U
z P
Duration of 
Iniection Historv: 
In Treatment 
Not in Treatment
58
23
46.59
26.91
2702
619
343 -3.4 0.001
Frequency of Iniectine 
In Treatment 58 
Not In Treatment 23
37.50
50.91
2175
1171
464 -2.5 0.028
Freauencv of Borrowing 
Needles/Svrinees 
In Treatment 58 
Out o f Treatment 23
38.97
46.11
2260.5
1060.5
549 -1.1 non­
significant
Frequency o f Borrowing 
SDOons/Filters3 
In Treatment 58 
Not in Treatment 23
36.80
51.59
2134
1186
423.5 -2.6 0.008
Hepatitis C Knowledge 
In Treatment 
Out of Treatment
58
23
41.2
40.5
2389.5
931.5
655.5 -1.2 non­
significant
Peer Group Risk 
Behaviour 
In Treatment 
Out of Treatment
58
23
42.61
36.93
2471.5
849.5
573.5 -0.9 non­
significant
Self-efficacv 
In Treatment 
Out of Treatment
58
23
39.06
45.89
2265.5
1055.5
554.5 -1.2 non­
significant
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Table 5: Injecting Risk Behaviour
Variable In-Treatment 
Sample
Out of Treatment Total
Age began injecting:
Mean 22 24 23
Sd 5.5 7.3 6.1
Duration of Injecting History (yrs)*:
Mean (yrs) 5 2 5
Sd 6 4 6
Freq borrowed needles (6 months):
Mean (no. o f times) 6 11 8
Median 0 2 0
Range 97 120 120
Freq lend needles (6 months):
Mean (no. o f times) 8 10 8
Median 2 0 2
Range 90 150 150
Frequency Borrowed spoons/filters (6 months):*
Mean (no. o f times) 5 105 33
Median 1 10 2
Range 60 600 60
* P<0.01 Mann Whitney U
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CLINICAL CASE RESEARCH STUDY 1 (ABSTRACT)
Psychological Management of Mania for a Client with concurrent Learning
Difficulties
Lisa Cameron, Department of Psychological Medicine, 
University of Glasgow.
Written in accordance for submission to Journal of Intellectual Disability Research
Abstract
Background The following individual case study involved psychological treatment 
of Bipolar disorder in a client with a concurrent learning disability. Despite the 
finding that approximately 6% of people with learning disabilities also have a serious 
mental health difficulty, research has often neglected to apply psychological 
treatments of serious mental illness to learning disabled clients. Method In the 
present study, a psychological intervention for Bipolar disorder involving both 
Prodromal Symptom Monitoring and an Inpatient Family Intervention was adapted 
to the level of understanding and social context of a learning disabled client.
Results Treatment outcome was favourable, demonstrating improvement in terms of 
reduced relapse and increased coping. These gains were maintained at 9 months 
follow-up. Conclusion The author concludes that further application of these 
interventions for clients with a dual diagnosis of learning disability and serious 
mental illness is merited.
Key words: Bipolar Disorder, 
Intellectual Disability.
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CLINICAL CASE RESEARCH STUDY 2 (ABSTRACT)
Treatment of Urinary Urgency in a Ten Year Old Boy using Combined Biadder 
Retention Training and Cognitive-Behaviour Therapy.
Lisa Cameron, Department of Psychological Medicine, 
University of Glasgow.
Written in accordance for submission to Clinical Child Psychology and Psychiatry
Abstract
This single case study involved Cognitive-Behaviour therapy for Urinary Urgency in 
a 10-year old boy. Urinary Urgency is infrequently documented in both the adult and 
child literature, although enuresis a similar condition does commonly occur within 
childhood. Treatment was undertaken during 6 sessions. It followed the Cognitive- 
Behaviour therapy format for children described by Kendall (1994), and also 
involved Bladder Retention Training. Treatment outcome demonstrated reduction in 
both anxiety and depression measures. Avoidance behaviours were also 
substantially reduced whilst ratings of ‘confidence over bladder control’ improved. 
Treatment gains were maintained at 6 months follow-up. Outcome from this case 
study suggests that coupled with Bladder Retention Training, Cognitive-Behaviour 
therapy can be successfully applied to Urinary Urgency problems within childhood.
Key Words: Childhood Urinary 
Urgency, Cognitive-Behaviour 
Therapy
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CLINICAL CASE RESARCH STUDY 3 (ABSTRACT)
Comparison of a Standard Anxiety Management Programme 
for Older Adults with a Tailored Anxiety Management Programme.
Lisa Cameron, Department of Psychological Medicine, 
University of Glasgow.
Written in accordance for submission to International Journal of Geriatric Psychiatry
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Abstract
The current study compared a standard group anxiety management programme for older 
adults with a group anxiety management programme which was tailored to address the 
types of anxiety which commonly present in late life. Each programme followed a 
Cognitive-Behavioural approach and was undertaken over 8 weekly sessions. The 
tailored group programme included topics such as death anxiety, anxieties about ill- 
health and fear of violence. Outcome from both treatment groups were compared with a 
waiting list control. Overall, results suggested that group anxiety management can 
reduce anxiety symptoms for some older adults. Slightly more improvement was 
demonstrated by clients who took part in the tailored group programme, suggesting that 
it may be beneficial to adapt anxiety management for older adults. The symptoms of 
participants in the waiting-list control group did not evidence change suggesting that 
improvement made by those in the treatment conditions occurred as a result of 
intervention. Outcome from the case study is discussed in relation to the current 
literature.
Key words: Anxiety Management, Older
Adults.
91
Appendix 1:
Small Scale Service Evaluation Project
1. Authors Notes -  Clinical Psychology Forum 
2.0uestionnaire
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Clinical Psychology Forum
Clinical Psychology Forum is produced by the Division of Clinical Psychology of the British 
Psychological Society. It is edited by Steve Baldwin, Lorraine Bell, Jonathon Calder, Lesley Cohen, 
Simon Gelsthorpe, Laura Golding, Helen Jones, Craig Newnes, Mark Rapley and Arlene Vetere and 
circulated to all members of the Division monthly. It is designed to serve as a discussion forum for 
any issues of relevance to clinical psychologists. The editorial collective welcomes brief articles, 
reports of events, correspondence, book reviews and announcements.
Notes for contributors
Articles of 1000-2000 words are welcomed. Shorter 
articles can be published sooner. Please check any 
references. Send two copies of your contribution, 
typed and double-spaced. Contributors are asked to 
keep tables to a minimum; use text where possible.
News of Branches and Special Groups is 
especially welcome.
Language: contributors are asked to use 
language which is psychologically descriptive rather 
than medical and to avoid using devaluing 
terminology; i.e.: avoid clustering terminology like 
“the elderly” or medical jargon like “schizophrenic”. 
Articles submitted to Forum will be sent to members 
of the Editorial Collective for refereeing. They will 
then communicate directly with authors.
Copy
Please send all copy and correspondence to the Co­
ordinating Editor:
Craig Newnes 
Field House 
1 Myddlewood 
Myddle
Shrewsbury SY4 3RY 
Tel and Fax: 01939 291209 
106071.666@compuserve.com
Division News
Please send all copy to:
Helen Jones
Psychology Consultancy Service 
Chaddeslode House 
130 Abbey Foregate 
Shrewsbury SY2 6AX 
Fax: 01743 352210 
Hiones9@compuserve.com
Book Reviews
Please send all book and review requests to the Book 
Reviews Editor:
Arlene Vetere 
Department of Psychology 
University of Reading 
White Knights 
Reading RG6 2AL 
Fax: 01734 316604 ,
Advertisements
Rates: advertisements not connected with DCP 
sponsored events are charged as follows:
Full page (20cm x 14cm): £140 
Half page (10cm by 14cm): £85 
Inside cover: £160
All these rates are inclusive of VAT and are subject 
to a ten per cent discount for publishers and agencies 
and a further 10 per cent discount if the 
advertisement is placed in four or more issues. DCP 
events are advertised free of charge. Advertisements 
are subject to the approval o f the Division of Clinical 
Psychology. Copy (preferably camera ready) should 
be sent to:
Jonathon Calder
The British Psychological Society
St Andrews House
48 Princes Road East
Leicester LEI 7DR
Tel: 0116 252 9501 (direct line)
Fax: 0116 247 0787 
Joncal@bps.org.uk
Publication of advertisements is not an endorsement 
of the advertiser nor of the products and services 
advertised.
Subscriptions
Subscription rates of Clinical Psychology Forum
are as follows:
US only: $160 
Outside US and UK: £80 
UK (Institutions): £60 
UK (Individuals): £30 
Subscriptions should be sent to:
Clinical Psychology Forum 
The British Psychological Society 
St Andrews House 
48 Princes Road East 
Leicester LEI 7DR 
Tel: 0116 254 9568 
Fax: 0116 247 0787
Clinical Psychology Forum is published monthly 
and is dispatched from the printers on the 
penultimate Thursday of the month prior to the 
month of publication.
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August, 1997.
To, Members of the Hamilton Community Mental Health Team. 
The Psychology department is keen to discover your views 
and ideas about its service to the Hamilton Community 
Mental Health Team. In order to do th is it would be 
helpful if  you could take a few m inutes o f your tim e to  
answer the following questions. (All responses are 
confidential).
1. Which of the following do you consider to be the m ain direct 
role(s) of Clinical Psychology within the Community Mental 
Health Team?
(Please tick up to five roles and rate their importance (e.g. 1= m ost 
important role, 2= second m ost important. 3= third m ost important etc.)
Tick Rating
Individual work with Clients
Discussion of New Referrals at Allocation meeting
Recommendation of Appropriate Therapy 
or course of Action
Psychological A ssessm ents
A ssessm ent of Memory and Cognitive functioning
Groupwork
Work with families, carers and staff
No Roles
Other (please specify)
2. Which additional indirect role(s) could Clinical Psychology 
undertake?
Please tick up to five roles and rate their usefulness (e.g l=m ost useful 
role, 2 = second most useful role etc.)
Tick Rating
Education/H ealth Promotion work (community)
Team training in Psychological issues
Audit of CMHT service
Research work
Consultation work with team members
Supervision with team members
No Roles
Other (please specify)
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3. Which types of CMHT cases do you most often refer to
Clinical Psychology?
Please tick the five m ost frequent types of case and rate (e.g. 1= m ost 
frequent type of case, 2 = second m ost frequent type of case etc.)
Tick 1lating
Schizophrenia
Severe Depression
Complex, Enduring Anxiety
Mania or Manic Depression
Obsessive Compulsive Disorder
Paranoia
Personality Disorders
Trauma (inch Sexual Abuse)
Multiple Problems (ie mania + relationship difficulties)
Other (please specify)
4. Why do^you choose to refer these particular cases to 
Psychology?
Please tick the three m ost usual reasons and rate them  (e.g. 1= m ost 
usual reason, 2= second most usual reason etc.)
Tick Rating
Psychological type problem
Complexity of case
Alternative opinion
Additional professional back-up
Enduring problem
Earliest available appointment
Other (please state)
5. How do you usually make referrals to Clinical Psychology 
within your team?
Please tick the most frequent referral procedure
Tick
Speak with
Write to
Complete Referral Form
Allocation meeting
Combination of Above (please specify)
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5. How often do you communicate with Clinical Psychology 
regarding team cases which you are both working on?
Never Not Often Often Very Often Always
6. How satisfied are you with the following aspects of the 
psychology service within your team?- 
Please choose from the following terms -
Very Satisfied Satisfied No opinion Dissatisfied Very Dissatisfied 
1 2 3 4 5
a) Ability to refer to psychology-------------
b) Opportunity to access a  psychological perspective on 
c a s e s --------------- .
c) Psychological work undertaken with the seriously 
mentally i l l-----------
d) Waiting time to see psychologist---------------
e) Degree of Psychological involvement in te a m -----------
7. In which of the following ways would you like to see the 
psychology service developed?
Please rate your first and second choice.
Rating
Staff training in psychological issues
Ongoing groupwork with Team members e.g. Relapse Prevention
Specialist groups e.g.hearing voices sufferers or depression
Work with family/carers
Formal meetings for discussion of complex cases
Other Development (please specify)
Thank you for your help.
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Appendix 2:
Major Research Project Literature Review
1. Authors Notes -  Addiction
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Addiction
Guidance to Authors
The editorial staff will be most grateful for your assistance in relation to the matters listed below. 
Please follow this guidance carefully when preparing a submission.
General matters
A d d ic tio n  is a refereed journal. Its goal is to serve international and interdisciplinary scientific and clinical 
communication, to strengthen links between science and policy, and to stimulate and enhance the quality 
of debate. Submissions are sought which are not only technically competent, but are original and contain 
information or ideas of fresh interest to our international readership. Books and major reports may be 
submitted for review, and material for the News and Notes section is welcomed. We seek to serve the 
developing as well as the developed world. We aim to handle submissions courteously and promptly, and 
welcome dialogue with our contributors and readers. We regret that we are not able to return manuscripts.
Ethical standards
Manuscripts are accepted on the understanding that they are subject to editorial revision. Submissions must 
be accompanied by a signed statement from all authors saying that: (a) the material has not been published 
in whole or in part elsewhere; (b) the paper is not currently being considered for publication elsewhere; (c) 
all authors have been personally and actively involved in substantive work leading to the report, and will 
hold themselves jointly and individually responsible for its content; (d) all relevant ethical safeguards have 
been met in relation to patient or subject protection, or animal experimentation. This statement must also 
declare sources of funding, direct or indirect, and any connection with the tobacco, alcohol or pharmaceu­
tical industries. With regard to points (a) and (b): if data from the same study are reported in more than one 
publication, this should be stated in the manuscript and/or covering letter to the editor, along with a clear 
explanation as to how the submitted manuscript differs, and copies of closely related manuscripts reporting 
these data should be enclosed. If at any stage during the handling of their submission, authors decide to 
withdraw it, we ask them to notify the editor.
Length
Submissions should be double spaced and clearly legible. There is no maximum length for articles. We ask 
authors to be as concise as possible and will negotiate with you personally and sympathetically if  we feel 
shortening would improve communication. Case reports are welcomed but should not be more than 6 pages. 
Letters should not be more than 2 pages.
Layout
Please submit four copies of each manuscript. They should be typed on one side o f the paper, double 
spaced, with margins of at least 25 mm. The first sheet should contain the title o f the paper, a short title 
not exceeding 45 characters, names of authors, the address where the work was carried out, and the full 
postal address of the author who will check proofs and receive correspondence and offprints. The second 
sheet should contain only the title, names of authors, and an abstract. Please send one extra loose copy of 
the abstract with submissions. The entire manuscript, including all references, tables, figures, and any other 
material, should be numbered in one sequence from the title page onwards. Please put at the bottom of the 
title page the to ta l  number of pages and, if possible, include a word count for the text and references 
(excluding title and abstract pages, tables and figures). Footnotes to the text should be avoided where 
possible.
Abstract
In the case of research reports, abstracts should use the following headings: Aims, Design, Setting, 
Participants, Intervention (experimental trials only), Measurements, Findings, and Conclusions. The 
findings should be clearly listed because it is the list of findings that will form the main basis for the editorial 
decision. Each finding will be evaluated in terms of its importance if true and the confidence that can 
be placed on it given the evidence. In the case of other types of paper, there are no formal requirements 
for the structure of abstracts but it must be clear from the abstract what conclusions are being drawn because 
evaluation of these will be central to the refereeing process. Abstracts should normally be no more than 250 
words.
References ,
These may be submitted in either the Harvard or Vancouver systems. When following the H a r v a r d  sy s te m  
references should be indicated in the typescript by giving the author’s name, with the year of publication 
in parentheses, e.g. Smith (1984); if there are three authors Smith, Green & Jones (1984) on the first citation 
and Smith e t  a l . (1984) subsequently; or if there are more than three authors Smith e t  a l. (1984) throughout. 
If several papers from the same authors and from the same year are cited, (a), (b), (c), etc. should be put 
after the year of publication. References should be listed at the end o f the paper in alphabetical order. 
Examples are:
Abrams, D. B. & W ilson, G. T. (1979) Effects o f alcohol on social anxiety in women: cognitive versus 
physiological processes, Jou rn a l o f  A b n o r m a l P s y c h o lo g y , 88, 161-173.
B l a n e ,  H. T. & L e o n a r d ,  K. E. (1987) P s y c h o lo g ic a l  T h e o r ie s  o f  D r in k in g  a n d  A lc o h o lis m  (New York, 
Guilford Press).
When following the V a n co u ve r sy stem  references should be numbered consecutively in the order in which 
they are first mentioned in the text. Identify references in text, tables, and legends by arabic numerals 
(in parentheses). References cited o n ly  in tables or in legends to figures should be numbered in accordance 
with a sequence established by the first mention in the text o f the particular table or illustration.
The references should be listed in numerical order at the end of the paper. Examples are:
1. C o t t o n ,  N. (1987) The familial incidence of alcoholism. J o u rn a l o f  S tu d ie s  on  A lc o h o l, 40, 89-116.
2. M e r i k a n g a s ,  K. R. (1989) Genetics o f alcoholism: a review of human studies, in: W e t t e r b e r g ,  I. (Ed.) 
G e n e tic s  o f  N e u ro p sy c h ia tr ic  D ise a se s , pp. 21-28 (London, Macmillan).
Whatever referencing system is adopted, titles o f journals should not be abbreviated. All authors should be 
included. The reference list should not be needlessly profligate and should only include items that are 
retrievable through standard bibliographic sources. Where foreign language papers or books are cited, the 
title in English needs to be included in brackets after the foreign language version.
Illustrations
These should not be inserted in the text but each provided separately and numbered on the back with Figure 
numbers, title of paper and name of author. Illustrations should be prepared about twice their final size. 
Three copies of all figures must be submitted. All photographs, graphs and diagrams should be referred to 
as Figures and should be numbered consecutively in the text in Arabic numerals (e.g. Fig 3). The 
approximate position of each illustration should be indicated in the text. A list of captions for the figures 
should be submitted on a separate sheet and should make interpretation possible without reference to the 
text. Captions should include keys to symbols.
Tables
These should be typed on separate sheets and their approximate position in the text should be indicated. 
Units should appear in parentheses in the column heading but not in the body of the table. Words or 
numerals should be repeated on successive lines ‘ditto’ or ‘do’ should not be used. Tables should not be 
ruled.
Proofs
Proofs are supplied for checking and making essential corrections, not for general revision or alteration. 
Proofs should be corrected and returned to the publisher within 3 days of receipt.
Offprints
Fifty offprints of each paper are supplied free. Additional copies may be purchased and should be ordered 
u hen the proofs are returned. Offprints, together with a complete copy of the relevant journal issue, are sent 
about three weeks after publication.
Refereeing
Papers will normally be sent by the Regional Editor for review to an Assistant Editor who will solicit 
referees’ reports and make a recommendation to the Regional Editor. The regional editor will make a 
decision on the paper and communicate this with the authors. The Regional Editor or the Assistant Editor 
may return a paper %unrefereed if in their judgement it is not suitable for the journal because of serious 
methodological limitations, the topic addressed or problems with reporting.
Appendix 3:
Major Research Project Proposal
1. Doctorate in Clinical Psychology Guidelines
2. Hepatitis C Questionnaire
3. Hepatitis C Information Sheet
4. Hepatitis C Consent Form
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RESEARCH PORTF OLI O G U I D E L I N E S  FOR MAJOR RESEARCH PROPOSAL
1.1 Applicants - names and addresses including the names of co-workers 
and supervisors) if known.
1.2 Title - no more than 15 words.
1.3 Summary - No more than 300 words, including a reference to where
the study will be carried out.
1.4 Introduction - of less than 600 words summarising previous work in 
the field, drawing attention to gaps in preserit Knowledge and stating 
how the project will add to knowledge and understanding.
1.5 Aims and hypothesis to be tested - these should wherever possible h* 
stated as a list of questions to which answers will be sought
1.6 Plan of investigation - consisting of a statement of the practical
details of how it is proposed to obtain answers to the questions posed. 
The proposal should contain information on Research Methods and 
Design i.e.
1.6.1 Subjects - a brief statement of inclusion and exclusion criteria 
and anticipated number of participants.
1.6.2 Measures - a brief explanation of interviews/observations/ 
rating scales etc. to be employed^mcluding references where 
appropriate.
1.6.3 Design and Procedure - a brief explanation of the overall 
experimental design with reference to comparisons to be 
made, control populations, timing of measurements, etc. A 
summary chart may be helpful to explain the research process.
1.6.4 Settings and equipment - a statement on the location(s) to be 
used and resources- or iquipmem wmcii writ uc empluyed (if
ami]
® V 7 '
1.6.5 Data analysis - a brief explanation of how data will be 
collated, stored and analysed.
1.7 Practical applications - the applicants should state the practical use to 
which the research findings could be put.
1.8 Timescales - the proposed starting date and duration of the project.
1.9 Ethical approval - stating whether this is necessary and, if so, whether 
it has been obtained.
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HEPATITIS C QUESTIONNAIRE
© Lisa Cameron September 1998
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SECTION 1: INTERVIEW INFORMATION
1. Initials:
2. Date of Birth:
3. Gender:
Male□ Female□
4. Marital Status Married Single Other □ □ □
5. What is your current living arrangement □
House/Flat N o Permanent 
Address□
6. At what age did you leave school?
7. What qualifications if any did you get, 
(mark number of each qualification in box)
8. Are you currently employed 
If yes, what is your current occupation
None O ’grades Highers 
□ □ □
Y es□ No□
Yes No
9. Are you currently having treatment because of 
your drug use? □ □
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Further
Education□
HE PA TITIS C IN  FORMA TION
1. Have you heard of hepatitis C ^ ^
Yes
1□
No
2. How likely do you think you are to develop hepatitis C?
Very Likely 
Unlikely
Very
Likely
2. Do you know anyone who is infected with hepatitis C □ □
Yes No
4. Have you ever had a Hepatitis C test
□ □
4 (a). Would you mind telling me the result ?
Yes No
4 (b). If positive, how, if at all has this altered your drug use
5. How serious a risk do you consider hepatitis C in comparison to the other risks 
involved in your drug use
Not at all Somewhat 
Serious Serious
Very
Serious
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The following are statements about Hepatitis C. Please decide whether 
you think they are true or false by ticking the appropriate box:-
True False
1. Hepatitis C can cause lung damage □ □
2. Having a tattoo done with an unsterilized needle can give you 
Hepatitis C. □ □
3. Treatment for hepatitis C is very effective? □ □
4. You can catch hepatitis C through using a razor which belongs 
to someone who is infected. □ □
5. Cleaning needles with bleach always protects against hepatitis C. □ □
6. You can catch Hepatitis C by using spoons/filters 
after someone who is infected. □ □
7. Hepatitis C is easily transmitted through unprotected 
sexual intercourse. □ □
S.. It is possible to catch hepatitis C by using the same rinsing water 
(for drugs) as someone who is infected □ □
9. You can catch hepatitis C through sharing your toothbrush 
with someone who is infected. □ □
10. Injecting drug users often catch hepatitis C.
□ □
11. You should try not to drink alcohol if you have Hepatitis C.
□ □
12. You can get vaccinated against hepatitis C. □ □
13. If someone who is pregnant catches Hepatitis C their unborn baby 
can catch it. □ □
14. You need to clean needles in bleach for 30 seconds to kill 
hepatitis C.
□ □
15. Hepatitis C virus survives in dried blood for only a few minutes. □ □
16. You can catch hepatitis C the first time you use unsterilized 
needles'. □ □
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RECENT BEHA V1QUR
1! How old were you when you first started injecting drugs?
2. How long have you been injecting drugs for?
3. How often do you currently inject drugs
Not Somewhat Often
Often Often
(i.e. less than (about once
once per month) a month) a week)
Very 
Often 
(about once 
once a day)
4. When you inject drugs how often is it with other drug users?
Not
Often
Somewhat
Often
Often Very
Often
(i.e. more than
5.When you injected in the last 6 months, how often was it with used needles and 
syringes?
Not
Often
Somewhat Often 
Often
Very
Often
Never
6.How many times did you borrow used needles and syringes in the last 6 months?
7.1n the last 6 months when you used needles or syringes someone else had used before 
you, how often did you clean them first?
Not
Often
Somewhat
Often
Often Very
Often
8.1f cleaned somebody clsc’s syringes, how did you normally clean them?
Adequate/Inadequate
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9. How many times did you lend/pass on used needles and syringes in the last 6 months?
10. 10. In the last 6 months, how many times did you use borrowed spoons and filters?
1 l .How Often did you clean them first?
Not Somewhat Often Very
Often Often Often
12. If cleaned equipment, how do you usually clean it?
Adequate/Inadequate
13. How often in the last 6 months did you pass on someone spoons and filters which 
you had already used?
Not Somewhat Often Very
Often Often Often
Never
14. How often in the last 6 months have you had unprotected sexual intercourse 
(including with your partner)?
Not Somewhat Often Very
Often Often Often
15. How often in the last 6 months has someone squirted drugs from their syringe into 
yours for your use?
Not Somewhat Often Very
Often Often Often
16. How often in the last six months have you injected drugs in a ‘shooting gallery’? 
(a room/building where lots of drug users inject)
Not Somewhat Often Very
Often Often Often
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17. How often in the last 6 months have you squirted drugs from your syringe into 
someone else’s syringe for their use?
Not Somewhat Often Very
Often Often Often
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The following questions relate to your feelings about future behaviours. 
Please mark where your opinion lies on each line with a cross.
1. I am confident that I can avoid borrowing used needles even if my friends are 
sharing
Completely Mainly Somewhat Mainly Completely
Untrue Untrue True True True
2. I am confident that I will always clean used works (spoons/filters) with bleach 
before use
Completely Mainly Somewhat Mainly Completely
Untrue Untrue True True True
3. I am.sure that I will not use borrowed filters/spoons unless I clean them with bleach 
first
Completely Mainly Somewhat Mainly Completely
Untrue Untrue True True True
I am certain that I will not borrow another drug users’ toothbrush
Completely Mainly Somewhat Mainly Completely
Untrue Untrue True True True
5. I am confident that I will not use borrowed needles unless I clean them with bleach
Completely Mainly Somewhat Mainly Completely
Untrue Untrue True True True
6. I am certain that I can avoid lending/passing on used needles to other people in the 
near future
Completely Mainly Somewhat Mainly Completely
Untrue Untrue True True True
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7. T am sure that T will not squirt drugs from someone else’s syringe into mine in the 
near future_________________________________________________
Completely Mainly Somewhat Mainly Completely
Untrue Untrue True True True
8. I am certain that I will not have sexual intercourse without using a condom 
(including with my partner).
Completely Mainly Somewhat Mainly Completely
Untrue Untrue True True True
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The following questions are about attitudes which important people 
in your life may or may not hold. Please mark where you believe 
their attitudes to lie on the line with a cross.
1. Most people T know think that you should use condoms when having sexual 
intercourse (including with partner).
Completely Mainly Somewhat Mainly Completely
True True True Untrue Untrue
2. My friends believe that you should always clean borrowed spoons with bleach before 
use
Completely Mainly Somewhat Mainly Completely
* True True True Untrue Untrue
3. I feel under social pressure to borrow used injecting equipment
Completely Mainly Somewhat Mainly Completely
True True True Untrue Untrue
4. Drug users I know think that I should lend them (pass on) needles/syringes
Completely Mainly Somewhat Mainly Completely
True True True Untrue Untrue
5. Most people I know do not use condoms during sexual intercourse (including with 
partner).
Completely Mainly Somewhat Mainly Completely
True True True Untrue Untrue
6. Drug users I know always clean used needles with bleach before use
Completely Mainly Somewhat Mainly Completely
True True True Untrue Untrue*
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7. Friends I know think it is alright to share your toothbrush
Completely Mainly Somewhat Mainly Completely
True True True Untrue Untrue
8. Drug users I know disapprove of cleaning shared works with bleach
Completely Mainly Somewhat Mainly Completely 
True True True Untrue Untrue
9. My friends would disapprove if I re-used works without cleaning them first
Completely Mainly Somewhat Mainly Completely 
True True True Untrue Untrue
10. Drug users I know often squirt drugs from other peoples syringes into theirs for their 
use
Completely Mainly Somewhat Mainly Completely 
True True True Untrue Untrue
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Information Sheet 
For patients/volunteers in a clinical research study 
Project Title:
Hepatitis C risk behaviours and drug user’s sense of control, knowledge and
peer group norms.
Patient/volunteer summary:
• You are being invited to take part in a research study. Your participation 
in this study may not be of direct benefit to you but could help in the 
development of treatment for the benefit of future patients.
• Taking part in the study involves completing one twenty-minute 
interview with the researcher. There are no other requirements of the 
research.
• The study hopes to look at some of the reasons why people undertake 
behaviours which may put them at risk for hepatitis C. We are interested 
in finding out about your understanding of hepatitis Q  your attitudes and 
about the attitudes of the people you know. Part of the study will also 
ask you about possible past risk behaviours.
• Confidentiality of your responses shall be maintained and shall not be 
passed on to any treatment agency which you are involved with. Alt 
identifying information shall be kept separately from your interview 
responses in order that your views remain confidential.
• If you do not want to take part in this study or wish to withdraw at any 
time after commencing, you may do so without the need to give an 
explanation and your care will not be affected in any way .____________
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PATIENT OR VOLUNTEER CONSENT TO PARTICIPATE IN RESEARCH
STUDY
Project Title
Hepatitis C Risk Behaviours and drug user's perception o f control. knowledge and peer 
group norms.
• You should have been given a complete explanation of the research study in which 
you are being invited to take part, including details of the procedures and treatment 
you would undergo as part of the study.
• You should have had the opportunity to ask questions.
• You should have received the information sheet on the study which has been 
approved by Lanarkshire Health Board Ethics of Research Committee, which you 
should have read and should keep.
• There is no obligation to take part in the study and you need not give any reason if 
you do not wish to take part in the study.
• You may withdraw from the study at any time without the need to give a reason and 
without any effect upon your normal care.
Consent
I ...............................................................................................................(name in capitals)
Of
.............................................................................................................. (address in capitals)
... .agree to take part in this research project, the nature, purpose and possible 
consequences of which have been described tom e....
b y ......................... LISA CAMERON................................................(name in capitals)
Subject signature
.............................................................................................................  D ated ...................
Researcher signature
This form has been approved by Lanarkshire Health Board Ethics of Research Committee
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Major Research Project Paper
1. Authors Notes -  Addiction
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5. Percentage Table of Peer-group Norm Responses
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Guidance to Authors
The editorial staff will be most grateful for your assistance in relation to the matters listed below. 
Please follow this guidance carefully when preparing a submission.
General matters
A d d ic tio n  is a refereed journal. Its goal is to serve international and interdisciplinary scientific and clinical 
communication, to strengthen links between science and policy, and to stimulate and enhance the quality 
of debate. Submissions are sought which are not only technically competent, but are original and contain 
information or ideas of fresh interest to our international readership. Books and major reports may be 
submitted for review, and material for the News and Notes section is welcomed. We seek to serve the 
developing as well as the developed world. We aim to handle submissions courteously and promptly, and 
welcome dialogue with our contributors and readers. We regret that we are not able to return manuscripts.
Ethical standards
Manuscripts are accepted on the understanding that they are subject to editorial revision. Submissions must 
be accompanied by a signed statement from all authors saying that: (a) the material has not been published 
in whole or in part elsewhere; (b) the paper is not currently being considered for publication elsewhere; (c) 
all authors have been personally and actively involved in substantive work leading to the report, and will 
hold themselves jointly and individually responsible for its content; (d) all relevant ethical safeguards have 
been met in relation to patient or subject protection, or animal experimentation. This statement must also 
declare sources of funding, direct or indirect, and any connection with the tobacco, alcohol or pharmaceu­
tical industries. With regard to points (a) and (b): if data from the same study are reported in more than one 
publication, this should be stated in the manuscript and/or covering letter to the editor, along with a clear 
explanation as to how the submitted manuscript differs, and copies o f closely related manuscripts reporting 
these data should be enclosed. If at any stage during the handling of their submission, authors decide to 
withdraw it, we ask them to notify the editor.
Length
Submissions should be double spaced and clearly legible. There is no maximum length for articles. We ask 
authors to be as concise as possible and will negotiate with you personally and sympathetically if we feel 
shortening would improve communication. Case reports are welcomed but should not be more than 6 pages. 
Letters should not be more than 2 pages.
Layout
Please submit four copies of each manuscript. They should be typed on one side of the paper, double 
spaced, with margins of at least 25 mm. The first sheet should contain the title of the paper, a short title 
not exceeding 45 characters, names o f authors, the address where the work was carried out, and the full 
postal address of the author who will check proofs and receive correspondence and offprints. The second 
sheet should contain only the title, names of authors, and an abstract. Please send one extra loose copy of 
the abstract with submissions. The entire manuscript, including all references, tables, figures, and any other 
material, should be numbered in one sequence from the title page onwards. Please put at the bottom of the 
title page the to ta l  number of pages and, if possible, include a word count for the text and references 
(excluding title and abstract pages, tables and figures). Footnotes to the text should be avoided where 
possible.
Abstract
In the case of research reports, abstracts should use the following headings: Aims, Design, Setting, 
Participants, Intervention (experimental trials only), Measurements, Findings, and Conclusions. The 
findings should be clearly listed because it is the list of findings that will form the main basis for the editorial 
decision. Each finding will be evaluated in terms of its importance if true and the confidence that can 
be placed on it given the evidence. In the case of other types of paper, there are no formal requirements 
for the structure of abstracts but it must be clear from the abstract what conclusions are being drawn because 
evaluation of these will be central to the refereeing process. Abstracts should normally be no more than 250 
words.
References
These may be submitted in either the Harvard or Vancouver systems. When following the H a r v a rd  sy s te m  
references should be indicated in the typescript by giving the author’s name, with the year of publication 
in parentheses, e.g. Smith (1984); if there are three authors Smith, Green & Jones (1984) on the first citation 
and Smith e t a l. (1984) subsequently ; or if there are more than three authors Smith e t  a l. (1984) throughout 
If several papers from the same authors and from the same year are cited, (a), (b), (c), etc. should be put 
after the year of publication. References should be listed at the end o f the paper in alphabetical order. 
Examples are:
A b r a m s ,  D. B. & W i l s o n ,  G. T. (1979) Effects of alcohol on social anxiety in women: cognitive versus 
physiological processes, J o u rn a l o f  A b n o r m a l P s y c h o lo g y ,  88, 161-173.
B l a n e ,  H. T. & L e o n a r d ,  K. E. (1987) P s y c h o lo g ic a l  T h e o r ie s  o f  D r in k in g  a n d  A lc o h o lis m  (New York, 
Guilford Press).
When following the V a n c o u v e r  sy s te m  references should be numbered consecutively in the order in which 
they are first mentioned in the text. Identify references in text, tables, and legends by arabic numerals 
(in parentheses). References cited o n ly  in tables or in legends to figures should be numbered in accordance 
with a sequence established by the first mention in the text of the particular table or illustration.
The references should be listed in numerical order at the end of the paper. Examples are:
1. C o t t o n ,  N. (1987) The familial incidence of alcoholism. J o u rn a l o f  S tu d ie s  on  A lc o h o l, 40, 89-116.
2. M e r i k a n g a s ,  K. R.'(1989) Genetics o f alcoholism: a review of human studies, in: W e t t e r b e r g ,  I. (Ed.) 
G e n e tic s  o f  N e u r o p sy c h ia tr ic  D is e a s e s , pp. 21-28 (London, Macmillan).
Whatever referencing system is adopted, titles of journals should not be abbreviated. All authors should be 
included. The reference list should not be needlessly profligate and should only include items that are 
retrievable through standard bibliographic sources. Where foreign language papers or books are cited, the 
title in English needs to be included in brackets after the foreign language version.
Illustrations
These should not be inserted in the text but each provided separately and numbered on the back with Figure 
numbers, title of paper and name of author. Illustrations should be prepared about twice their final size. 
Three copies of all figures must be submitted. All photographs, graphs and diagrams should be referred to 
as Figures and should be numbered consecutively in the text in Arabic numerals (e.g. Fig 3). The 
approximate position of each illustration should be indicated in the text. A list of captions for the figures 
should be submitted on a separate sheet and should make interpretation possible without reference to the 
text. Captions should include keys to symbols.
Tables
These should be typed on separate sheets and their approximate position in the text should be indicated. 
Units should appear in parentheses in the column heading but not in the body of the table. Words or 
numerals should be repeated on successive lines ‘ditto’ or ‘do’ should not be used. Tables should not be
ruled.
Proofs
Proofs are supplied for checking and making essential corrections, not for general revision or alteration. 
Proofs should be corrected and returned to the publisher within 3 days of receipt.
Offprints
Fifty offprints of each paper are supplied free. Additional copies may be purchased and should be ordered 
uhen the proofs are returned. Offprints, together with a complete copy of the relevant journal issue, are sent 
about three weeks after publication.
Refereeing
Papers will normally be sent by the Regional Editor for review to an Assistant Editor who will solicit 
referees’ reports and make a recommendation to the Regional Editor. The regional editor will make a 
decision on the paper and communicate this with the authors. The Regional Editor or the Assistant Editor 
may return a paper'unrefereed if in their judgement it is not suitable for the journal because of serious 
methodological limitations, the topic addressed or problems with reporting.
Internal'Consistencv o f the B €V  Questionnaire
Scale n Alpha
1. Knowledge of HCV 16 0.68
2. Injecting.RiskBehaviours 17 0.17
0.56 (if “frequency of sterilising equipment” is 
removed);
3. Sexual Risk Questions 4 0:81
4. “Peer Group Norms”' TO 0:42
0.51 (if “sexual” and “household” norms 
are removed).
5. Self-efficacy 8 0.36
0.68 (if self-efficacy for sexual risks and 
lending needles are removed).
Note: Future research shail involve validation and standardisation of the HCV scale. To 
date, internal consistency has been analysed using Cronbach’s coefficient alpha. Alpha 
measures of 0:6 8c 0.7 are currently defined as good/adequate within the literature [Clark, A. 
& Watson, D. (1995). Psychological Assessment, 7, 309-319.]. Some aspects o f the scale 
will therefore benefit from being adapted for future research.
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Appendix 4
Alterations Made to the HCV Questionnaire following Pilot Study
In response to the pilot study the following alterations were made to the HCV
questionnaire
1. A “never” category was included in relation to sharing needles/paraphernalia 
riuring-the last 6 -months. Prior to  this the interviewer had had to write never and 
n/a next to the question.
2. Questions 8 & 9 of the peer norm scale & 2 of the self-efficacy scale were altered 
from citing ‘works’ t&‘spoons/filters’ in order that consistency of interpretation 
of these questions was ensured.
3. The scales used within the questionnaire were altered from visual-analogue using 
two anchor points to ordinal using four or five anchor points. During the pilot 
study there was confusion as to interpretation of the visual-analogue scale. An 
ordinal scale was therefore easier to comprehend and ensured some consistency 
between participant responses. The responses from participants from the pilot 
study were re-classified according to their position on the four/five point scale.
Not Often Somewhat Often Very Often
Often
Example 1: Amended scale
Not Often Very Often
Example 2: Original scale
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